AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|37|198853824|Female|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|145|198853824|Female|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40145405|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39687165|Female|All other|2018|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Malignant|119|39687165|Female|All other|2018|0.2|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|45|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40632733|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40459557|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40208756|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40150534|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|155|198853824|Female|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40145405|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40164077|Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40141466|Female|Anaplastic astrocytoma|2017|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39687165|Female|Anaplastic astrocytoma|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40632733|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40459557|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|40305208|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|102|40208756|Female|Astrocytoma, NOS|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|103|40150534|Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|415|198853824|Female|Astrocytoma, NOS|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40145405|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40164077|Female|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|77|40141466|Female|Astrocytoma, NOS|2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|81|39687165|Female|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632733|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40459557|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40305208|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40305208|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40208756|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40208756|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40150534|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40150534|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|136|198853824|Female|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|41|198853824|Female|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|31|40145405|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40145405|Female|Choroid plexus|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40164077|Female|Choroid plexus|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Choroid plexus|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40141466|Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Choroid plexus|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|39687165|Female|Choroid plexus|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Choroid plexus|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40632733|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|40459557|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40305208|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40208756|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40150534|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|366|198853824|Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|198853824|Female|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|40145405|Female|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40164077|Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40164077|Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40141466|Female|Craniopharyngioma|2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40141466|Female|Craniopharyngioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|39687165|Female|Craniopharyngioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40632733|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|220|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|205|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|175|40632733|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40459557|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|40305208|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|40208756|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|212|40150534|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.4|0.5|0.5|Malignant|896|198853824|Female|Embryonal/primitive/medulloblastoma|2014-2018|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|191|40145405|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.4|0.5|0.4|Malignant|178|40164077|Female|Embryonal/primitive/medulloblastoma|2016|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.4|0.5|0.4|Malignant|170|40141466|Female|Embryonal/primitive/medulloblastoma|2017|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.3|0.5|0.4|Malignant|152|39687165|Female|Embryonal/primitive/medulloblastoma|2018|0.3|0.4|0.4
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40459557|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305208|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40305208|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40208756|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40208756|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|59|198853824|Female|Ependymoma variants|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|198853824|Female|Ependymoma variants|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40632733|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40459557|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40305208|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40208756|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40150534|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|419|198853824|Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40145405|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|79|40164077|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|40141466|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|39687165|Female|Ependymoma/anaplastic ependymoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40632733|Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|53|40632733|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40459557|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|36|40459557|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305208|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|21|40305208|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40208756|Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|47|40208756|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40150534|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40150534|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|104|198853824|Female|Germ Cell Tumors|2014-2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|222|198853824|Female|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40145405|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|46|40145405|Female|Germ Cell Tumors|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|40164077|Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|58|40164077|Female|Germ Cell Tumors|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Germ Cell Tumors|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40141466|Female|Germ Cell Tumors|2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|39687165|Female|Germ Cell Tumors|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|40|39687165|Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40632733|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40459557|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40305208|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40208756|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40150534|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Glioblastoma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|311|198853824|Female|Glioblastoma|2014-2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40145405|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|40164077|Female|Glioblastoma|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|40141466|Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.1|Malignant|54|39687165|Female|Glioblastoma|2018|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|234|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|237|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|268|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|297|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|264|40632733|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|20|40459557|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|312|40459557|Female|Glioma malignant, NOS|2011|0.7|0.9|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40305208|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|227|40305208|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.7|0.8|0.8|Malignant|304|40208756|Female|Glioma malignant, NOS|2013|0.7|0.8|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40150534|Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|271|40150534|Female|Glioma malignant, NOS|2014|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|99|198853824|Female|Glioma malignant, NOS|2014-2018|0.0|0.1|0.0
0-19|0.7|0.7|0.7|Malignant|1396|198853824|Female|Glioma malignant, NOS|2014-2018|0.7|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|16|40145405|Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|278|40145405|Female|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|23|40164077|Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|312|40164077|Female|Glioma malignant, NOS|2016|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|21|40141466|Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|310|40141466|Female|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|22|39687165|Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.7|0.6|Malignant|236|39687165|Female|Glioma malignant, NOS|2018|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40670476|Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40459557|Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40459557|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40208756|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40208756|Female|Hemangioblastoma|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|40150534|Female|Hemangioblastoma|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40150534|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|101|198853824|Female|Hemangioblastoma|2014-2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|198853824|Female|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40145405|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40145405|Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40164077|Female|Hemangioblastoma|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Hemangioblastoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39687165|Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39687165|Female|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39865121|Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40576293|Female|Hemangioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|40632733|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|40459557|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40305208|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40208756|Female|Hemangioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40150534|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|290|198853824|Female|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|198853824|Female|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|40145405|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|40164077|Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|40141466|Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39687165|Female|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|198853824|Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|198853824|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40632733|Female|Meningioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40459557|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459557|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40305208|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305208|Female|Meningioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40208756|Female|Meningioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40208756|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40150534|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40150534|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|330|198853824|Female|Meningioma|2014-2018|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|198853824|Female|Meningioma|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|68|40145405|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|40164077|Female|Meningioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40164077|Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40141466|Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40141466|Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|39687165|Female|Meningioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|198853824|Female|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|57|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|78|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40632733|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40459557|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|40305208|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|74|40208756|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40208756|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|80|40150534|Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40150534|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|323|198853824|Female|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|103|198853824|Female|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|81|40145405|Female|Neoplasm, unspecified|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40145405|Female|Neoplasm, unspecified|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40164077|Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40164077|Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|49|40141466|Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|21|40141466|Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|62|39687165|Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|39687165|Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Nerve sheath, benign and malignant|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|40632733|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40459557|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40305208|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305208|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|40208756|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40208756|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40150534|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40150534|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|583|198853824|Female|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198853824|Female|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40145405|Female|Nerve sheath, benign and malignant|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40145405|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40164077|Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40164077|Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40141466|Female|Nerve sheath, benign and malignant|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39687165|Female|Nerve sheath, benign and malignant|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39687165|Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40150534|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Neuroepithelial|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|198853824|Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40145405|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Neuroepithelial|2018|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|124|40165421|Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|134|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40632733|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|19|40632733|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|154|40459557|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40459557|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40305208|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|40305208|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|160|40208756|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|40208756|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|160|40150534|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40150534|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|829|198853824|Female|Neuronal/glial, neuronal|2014-2018|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|119|198853824|Female|Neuronal/glial, neuronal|2014-2018|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|170|40145405|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40145405|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|186|40164077|Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|29|40164077|Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|170|40141466|Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|22|40141466|Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|148|39687165|Female|Neuronal/glial, neuronal|2018|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|27|39687165|Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40632733|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40305208|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40208756|Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40150534|Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|198853824|Female|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|81|198853824|Female|Oligodendroglioma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40145405|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40164077|Female|Oligodendroglioma|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39687165|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40632733|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40459557|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459557|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40305208|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40305208|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40208756|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40208756|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|40150534|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40150534|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|231|198853824|Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|27|198853824|Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|40145405|Female|Other mesenchymal|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40145405|Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40164077|Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40164077|Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|40141466|Female|Other mesenchymal|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141466|Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|39687165|Female|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39687165|Female|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|323|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|319|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|339|40382360|Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|336|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|355|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|397|40632733|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|355|40459557|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|382|40305208|Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|365|40208756|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|407|40150534|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|0.0|0.0|0.0|Benign/Borderline|72|198853824|Female|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|1.0|0.9|Malignant|1804|198853824|Female|Pilocytic astrocytoma|2014-2018|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|358|40145405|Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.7|0.9|0.8|Malignant|325|40164077|Female|Pilocytic astrocytoma|2016|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Pilocytic astrocytoma|2017|~|~|~
0-19|0.9|1.1|1.0|Malignant|399|40141466|Female|Pilocytic astrocytoma|2017|0.9|1.1|1.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|39687165|Female|Pilocytic astrocytoma|2018|0.1|0.2|0.2
0-19|0.7|0.9|0.8|Malignant|329|39687165|Female|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632733|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40632733|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459557|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40459557|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305208|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40305208|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40208756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40208756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40150534|Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40150534|Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|20|198853824|Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|86|198853824|Female|Pineal parenchymal|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40145405|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40145405|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40164077|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Malignant|~|40164077|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141466|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|40141466|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39687165|Female|Pineal parenchymal|2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|39687165|Female|Pineal parenchymal|2018|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Benign/Borderline|277|39865121|Female|Pituitary|2004|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|318|39998876|Female|Pituitary|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|363|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|347|40382360|Female|Pituitary|2007|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|404|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|404|40670476|Female|Pituitary|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|466|40632733|Female|Pituitary|2010|1.0|1.3|1.1
0-19|~|~|~|Malignant|~|40632733|Female|Pituitary|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|471|40459557|Female|Pituitary|2011|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40459557|Female|Pituitary|2011|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|503|40305208|Female|Pituitary|2012|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|40305208|Female|Pituitary|2012|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|483|40208756|Female|Pituitary|2013|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40208756|Female|Pituitary|2013|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|532|40150534|Female|Pituitary|2014|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40150534|Female|Pituitary|2014|~|~|~
0-19|1.3|1.4|1.3|Benign/Borderline|2681|198853824|Female|Pituitary|2014-2018|1.3|1.4|1.3
0-19|~|~|~|Malignant|~|198853824|Female|Pituitary|2014-2018|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|523|40145405|Female|Pituitary|2015|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40145405|Female|Pituitary|2015|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|564|40164077|Female|Pituitary|2016|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40164077|Female|Pituitary|2016|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|563|40141466|Female|Pituitary|2017|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40141466|Female|Pituitary|2017|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|514|39687165|Female|Pituitary|2018|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|39687165|Female|Pituitary|2018|~|~|~
0-19|1.9|2.1|2.0|Benign/Borderline|799|39865121|Female|Total|2004|1.9|2.1|2.0
0-19|3.1|3.5|3.3|Malignant|1307|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.2|2.5|2.4|Benign/Borderline|965|39998876|Female|Total|2005|2.3|2.6|2.4
0-19|2.9|3.3|3.1|Malignant|1239|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|981|40165421|Female|Total|2006|2.3|2.6|2.4
0-19|2.9|3.2|3.1|Malignant|1228|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|993|40382360|Female|Total|2007|2.3|2.6|2.5
0-19|3.1|3.4|3.2|Malignant|1302|40382360|Female|Total|2007|3.1|3.4|3.2
0-19|2.5|2.8|2.6|Benign/Borderline|1082|40576293|Female|Total|2008|2.5|2.8|2.7
0-19|3.0|3.4|3.2|Malignant|1288|40576293|Female|Total|2008|3.0|3.4|3.2
0-19|2.5|2.8|2.7|Benign/Borderline|1103|40670476|Female|Total|2009|2.6|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1299|40670476|Female|Total|2009|3.0|3.4|3.2
0-19|2.7|3.0|2.9|Benign/Borderline|1180|40632733|Female|Total|2010|2.7|3.1|2.9
0-19|3.1|3.4|3.2|Malignant|1307|40632733|Female|Total|2010|3.0|3.4|3.2
0-19|2.8|3.1|3.0|Benign/Borderline|1215|40459557|Female|Total|2011|2.8|3.2|3.0
0-19|3.2|3.5|3.3|Malignant|1353|40459557|Female|Total|2011|3.2|3.5|3.3
0-19|2.9|3.3|3.1|Benign/Borderline|1266|40305208|Female|Total|2012|3.0|3.3|3.1
0-19|2.9|3.3|3.1|Malignant|1239|40305208|Female|Total|2012|2.9|3.3|3.1
0-19|3.0|3.4|3.2|Benign/Borderline|1287|40208756|Female|Total|2013|3.0|3.4|3.2
0-19|3.2|3.6|3.4|Malignant|1362|40208756|Female|Total|2013|3.2|3.6|3.4
0-19|3.0|3.4|3.2|Benign/Borderline|1295|40150534|Female|Total|2014|3.1|3.4|3.2
0-19|3.3|3.6|3.4|Malignant|1383|40150534|Female|Total|2014|3.3|3.6|3.4
0-19|3.1|3.3|3.2|Benign/Borderline|6355|198853824|Female|Total|2014-2018|3.1|3.3|3.2
0-19|3.1|3.3|3.2|Malignant|6324|198853824|Female|Total|2014-2018|3.1|3.3|3.2
0-19|3.1|3.5|3.3|Benign/Borderline|1325|40145405|Female|Total|2015|3.1|3.5|3.3
0-19|3.0|3.4|3.2|Malignant|1287|40145405|Female|Total|2015|3.0|3.4|3.2
0-19|3.1|3.4|3.2|Benign/Borderline|1312|40164077|Female|Total|2016|3.1|3.4|3.3
0-19|3.0|3.4|3.2|Malignant|1272|40164077|Female|Total|2016|3.0|3.3|3.2
0-19|3.0|3.3|3.1|Benign/Borderline|1270|40141466|Female|Total|2017|3.0|3.3|3.2
0-19|3.1|3.5|3.3|Malignant|1316|40141466|Female|Total|2017|3.1|3.5|3.3
0-19|2.8|3.2|3.0|Benign/Borderline|1193|39687165|Female|Total|2018|2.8|3.2|3.0
0-19|2.7|3.0|2.8|Malignant|1116|39687165|Female|Total|2018|2.6|3.0|2.8
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|134|40632733|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40459557|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40305208|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|40208756|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40150534|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|583|198853824|Female|Tumors of Cranial and Spinal Nerves|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198853824|Female|Tumors of Cranial and Spinal Nerves|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40145405|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|127|40164077|Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40141466|Female|Tumors of Cranial and Spinal Nerves|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39687165|Female|Tumors of Cranial and Spinal Nerves|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|191|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1209|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|198|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1148|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|204|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1158|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|229|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.3|3.1|Malignant|1239|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|229|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1233|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|215|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1219|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|233|40632733|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1226|40632733|Female|Tumors of Neuroepthelial Tissue|2010|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|248|40459557|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|1274|40459557|Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|254|40305208|Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.8|3.1|2.9|Malignant|1176|40305208|Female|Tumors of Neuroepthelial Tissue|2012|2.8|3.1|2.9
0-19|0.6|0.7|0.7|Benign/Borderline|264|40208756|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.7
0-19|3.0|3.3|3.2|Malignant|1273|40208756|Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.3|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|251|40150534|Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1309|40150534|Female|Tumors of Neuroepthelial Tissue|2014|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|1346|198853824|Female|Tumors of Neuroepthelial Tissue|2014-2018|0.6|0.7|0.7
0-19|2.9|3.1|3.0|Malignant|5913|198853824|Female|Tumors of Neuroepthelial Tissue|2014-2018|2.9|3.1|3.0
0-19|0.6|0.7|0.6|Benign/Borderline|254|40145405|Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.6
0-19|2.8|3.2|3.0|Malignant|1204|40145405|Female|Tumors of Neuroepthelial Tissue|2015|2.8|3.2|3.0
0-19|0.6|0.8|0.7|Benign/Borderline|277|40164077|Female|Tumors of Neuroepthelial Tissue|2016|0.6|0.8|0.7
0-19|2.7|3.1|2.9|Malignant|1169|40164077|Female|Tumors of Neuroepthelial Tissue|2016|2.7|3.1|2.9
0-19|0.6|0.8|0.7|Benign/Borderline|268|40141466|Female|Tumors of Neuroepthelial Tissue|2017|0.6|0.8|0.7
0-19|2.9|3.3|3.1|Malignant|1238|40141466|Female|Tumors of Neuroepthelial Tissue|2017|2.9|3.3|3.1
0-19|0.7|0.9|0.8|Benign/Borderline|308|39687165|Female|Tumors of Neuroepthelial Tissue|2018|0.7|0.9|0.8
0-19|2.5|2.8|2.6|Malignant|1038|39687165|Female|Tumors of Neuroepthelial Tissue|2018|2.5|2.8|2.6
0-19|0.8|1.0|0.9|Benign/Borderline|361|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|396|39998876|Female|Tumors of Sellar Region|2005|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|440|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|443|40382360|Female|Tumors of Sellar Region|2007|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|470|40576293|Female|Tumors of Sellar Region|2008|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|495|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|558|40632733|Female|Tumors of Sellar Region|2010|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.5|1.4|Benign/Borderline|558|40459557|Female|Tumors of Sellar Region|2011|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|581|40305208|Female|Tumors of Sellar Region|2012|1.3|1.6|1.4
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|572|40208756|Female|Tumors of Sellar Region|2013|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.4|1.7|1.5|Benign/Borderline|624|40150534|Female|Tumors of Sellar Region|2014|1.4|1.7|1.6
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.5|1.6|1.5|Benign/Borderline|3047|198853824|Female|Tumors of Sellar Region|2014-2018|1.5|1.6|1.5
0-19|~|~|~|Malignant|~|198853824|Female|Tumors of Sellar Region|2014-2018|~|~|~
0-19|1.4|1.6|1.5|Benign/Borderline|604|40145405|Female|Tumors of Sellar Region|2015|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.4|1.7|1.6|Benign/Borderline|632|40164077|Female|Tumors of Sellar Region|2016|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|642|40141466|Female|Tumors of Sellar Region|2017|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of Sellar Region|2017|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|565|39687165|Female|Tumors of Sellar Region|2018|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of Sellar Region|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|103|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|101|40632733|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632733|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40459557|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40459557|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40305208|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40305208|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|40208756|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40208756|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|144|40150534|Female|Tumors of the Meninges|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40150534|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|662|198853824|Female|Tumors of the Meninges|2014-2018|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|46|198853824|Female|Tumors of the Meninges|2014-2018|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|135|40145405|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40145405|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|142|40164077|Female|Tumors of the Meninges|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40164077|Female|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40141466|Female|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40141466|Female|Tumors of the Meninges|2017|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|39687165|Female|Tumors of the Meninges|2018|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|39687165|Female|Tumors of the Meninges|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|39865121|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|81|39998876|Female|Unclassified Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|83|40382360|Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|40576293|Female|Unclassified Tumors|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|133|40632733|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632733|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40459557|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|40459557|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|140|40305208|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40305208|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40208756|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40208756|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|146|40150534|Female|Unclassified Tumors|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|24|40150534|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|613|198853824|Female|Unclassified Tumors|2014-2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|109|198853824|Female|Unclassified Tumors|2014-2018|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|155|40145405|Female|Unclassified Tumors|2015|0.3|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40145405|Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|107|40164077|Female|Unclassified Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|25|40164077|Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|101|40141466|Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|40141466|Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|109|39687165|Female|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|39687165|Female|Unclassified Tumors|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|30|40632733|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632733|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40459557|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|23|40459557|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|34|40305208|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40305208|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|40208756|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40208756|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|41|40150534|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40150534|Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|121|198853824|Female|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|108|198853824|Female|Unique astrocytoma variants|2014-2018|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40145405|Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|26|40145405|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40164077|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|21|40164077|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40141466|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|40141466|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39687165|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|39687165|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|35|207689081|Male|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|155|207689081|Male|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41934839|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|41442486|Male|All other|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|117|41442486|Male|All other|2018|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42549015|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42367323|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42176956|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|42036128|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|41955322|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|215|207689081|Male|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|41934839|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|41942505|Male|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|41921243|Male|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41442486|Male|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|42549015|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|104|42367323|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42176956|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42036128|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|41955322|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|483|207689081|Male|Astrocytoma, NOS|2014-2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41934839|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|41942505|Male|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41921243|Male|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|41442486|Male|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42549015|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|42549015|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42367323|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42176956|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42036128|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41955322|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|177|207689081|Male|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|60|207689081|Male|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|41934839|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41934839|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|41942505|Male|Choroid plexus|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Choroid plexus|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41921243|Male|Choroid plexus|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Choroid plexus|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|41442486|Male|Choroid plexus|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Choroid plexus|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|41889233|Male|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42609915|Male|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42549015|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42549015|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|42367323|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|79|42176956|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42176956|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42036128|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42036128|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|41955322|Male|Craniopharyngioma|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41955322|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|468|207689081|Male|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|207689081|Male|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|41934839|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41934839|Male|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|41942505|Male|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41942505|Male|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|100|41921243|Male|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41921243|Male|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|41442486|Male|Craniopharyngioma|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42367323|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42176956|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Diffuse astrocytoma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|207689081|Male|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|295|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|299|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|322|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|314|42549015|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|42367323|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42176956|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|273|42036128|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.8|0.7|Malignant|281|41955322|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.6|0.7|0.7|Malignant|1355|207689081|Male|Embryonal/primitive/medulloblastoma|2014-2018|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|41934839|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.6|0.8|0.7|Malignant|288|41942505|Male|Embryonal/primitive/medulloblastoma|2016|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.6|0.8|0.7|Malignant|300|41921243|Male|Embryonal/primitive/medulloblastoma|2017|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.6|0.5|Malignant|198|41442486|Male|Embryonal/primitive/medulloblastoma|2018|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42549015|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42367323|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42176956|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42176956|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42036128|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42036128|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|86|207689081|Male|Ependymoma variants|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|207689081|Male|Ependymoma variants|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41934839|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41934839|Male|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|41942505|Male|Ependymoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|41921243|Male|Ependymoma variants|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41442486|Male|Ependymoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42549015|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367323|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42176956|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42036128|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41955322|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.3|0.3|Malignant|535|207689081|Male|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|41934839|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41942505|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|41921243|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|41442486|Male|Ependymoma/anaplastic ependymoma|2018|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|28|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|103|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|100|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|29|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|42549015|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|112|42549015|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|42367323|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|23|42176956|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42176956|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42036128|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42036128|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41955322|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|102|41955322|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|133|207689081|Male|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|530|207689081|Male|Germ Cell Tumors|2014-2018|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|19|41934839|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|106|41934839|Male|Germ Cell Tumors|2015|0.2|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|33|41942505|Male|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|41942505|Male|Germ Cell Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41921243|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|129|41921243|Male|Germ Cell Tumors|2017|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|31|41442486|Male|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|87|41442486|Male|Germ Cell Tumors|2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42549015|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|42367323|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42176956|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|42036128|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41955322|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Glioblastoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|387|207689081|Male|Glioblastoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41934839|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Glioblastoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41942505|Male|Glioblastoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|41921243|Male|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41442486|Male|Glioblastoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|228|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|223|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42158997|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42549015|Male|Glioma malignant, NOS|2010|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|283|42367323|Male|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|42176956|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|281|42176956|Male|Glioma malignant, NOS|2012|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|42036128|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|273|42036128|Male|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|23|41955322|Male|Glioma malignant, NOS|2014|0.0|0.1|0.1
0-19|0.6|0.7|0.6|Malignant|264|41955322|Male|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.1|0.1|0.1|Benign/Borderline|127|207689081|Male|Glioma malignant, NOS|2014-2018|0.1|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|1388|207689081|Male|Glioma malignant, NOS|2014-2018|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|22|41934839|Male|Glioma malignant, NOS|2015|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|304|41934839|Male|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|30|41942505|Male|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|296|41942505|Male|Glioma malignant, NOS|2016|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|22|41921243|Male|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|322|41921243|Male|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.1|0.1|0.1|Benign/Borderline|31|41442486|Male|Glioma malignant, NOS|2018|0.1|0.1|0.1
0-19|0.4|0.6|0.5|Malignant|209|41442486|Male|Glioma malignant, NOS|2018|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42367323|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42176956|Male|Hemangioblastoma|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42036128|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42036128|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41955322|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41955322|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|90|207689081|Male|Hemangioblastoma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|207689081|Male|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41934839|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41934839|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41942505|Male|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41942505|Male|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41921243|Male|Hemangioblastoma|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Hemangioblastoma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Hemangioblastoma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41889233|Male|Hemangioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42549015|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|42367323|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|42176956|Male|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42176956|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42036128|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41955322|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|306|207689081|Male|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|207689081|Male|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|41934839|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41934839|Male|Hemangioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41942505|Male|Hemangioma|2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41942505|Male|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|41921243|Male|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|41442486|Male|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|43|207689081|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42549015|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|42367323|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|42176956|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42036128|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41955322|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|316|207689081|Male|Meningioma|2014-2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|207689081|Male|Meningioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|41934839|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41934839|Male|Meningioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41942505|Male|Meningioma|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41921243|Male|Meningioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|41442486|Male|Meningioma|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42549015|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|207689081|Male|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|54|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|91|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|80|42549015|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42549015|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|71|42367323|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367323|Male|Neoplasm, unspecified|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42176956|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|29|42176956|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|42036128|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42036128|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|41955322|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41955322|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|329|207689081|Male|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|110|207689081|Male|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|41934839|Male|Neoplasm, unspecified|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|21|41934839|Male|Neoplasm, unspecified|2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|67|41942505|Male|Neoplasm, unspecified|2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|41942505|Male|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|41921243|Male|Neoplasm, unspecified|2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|29|41921243|Male|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|41442486|Male|Neoplasm, unspecified|2018|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|41442486|Male|Neoplasm, unspecified|2018|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|173|42158997|Male|Nerve sheath, benign and malignant|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42549015|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367323|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367323|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42176956|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|163|42036128|Male|Nerve sheath, benign and malignant|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|147|41955322|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955322|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|674|207689081|Male|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|207689081|Male|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|41934839|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|41942505|Male|Nerve sheath, benign and malignant|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41942505|Male|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|41921243|Male|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41442486|Male|Nerve sheath, benign and malignant|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42367323|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42176956|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42036128|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41955322|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Neuroepithelial|2014-2018|~|~|~
0-19|~|~|~|Malignant|~|207689081|Male|Neuroepithelial|2014-2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41934839|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|41942505|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Neuroepithelial|2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|174|42367071|Male|Neuronal/glial, neuronal|2007|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|178|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|173|42549015|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42549015|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|190|42367323|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|21|42367323|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|42176956|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|20|42176956|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|191|42036128|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|42036128|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|173|41955322|Male|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|31|41955322|Male|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.5|0.5|0.5|Benign/Borderline|1033|207689081|Male|Neuronal/glial, neuronal|2014-2018|0.5|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|121|207689081|Male|Neuronal/glial, neuronal|2014-2018|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|216|41934839|Male|Neuronal/glial, neuronal|2015|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41934839|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|226|41942505|Male|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41942505|Male|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|227|41921243|Male|Neuronal/glial, neuronal|2017|0.5|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|17|41921243|Male|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|197|41442486|Male|Neuronal/glial, neuronal|2018|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|41442486|Male|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42549015|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367323|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42176956|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42036128|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41955322|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|207689081|Male|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|80|207689081|Male|Oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41934839|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41942505|Male|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549015|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549015|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367323|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367323|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|42176956|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42176956|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42036128|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42036128|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41955322|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41955322|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|207|207689081|Male|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|37|207689081|Male|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|41934839|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41934839|Male|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|41942505|Male|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41942505|Male|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|41921243|Male|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41921243|Male|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|41442486|Male|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41442486|Male|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|352|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|358|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|348|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|396|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|366|42609915|Male|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|378|42549015|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|400|42367323|Male|Pilocytic astrocytoma|2011|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|425|42176956|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|434|42036128|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|381|41955322|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|0.0|0.0|0.0|Benign/Borderline|60|207689081|Male|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|1.0|0.9|Malignant|1911|207689081|Male|Pilocytic astrocytoma|2014-2018|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|381|41934839|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|1.0|0.9|Malignant|382|41942505|Male|Pilocytic astrocytoma|2016|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Pilocytic astrocytoma|2017|~|~|~
0-19|1.0|1.2|1.0|Malignant|439|41921243|Male|Pilocytic astrocytoma|2017|1.0|1.1|1.0
0-19|0.1|0.2|0.1|Benign/Borderline|60|41442486|Male|Pilocytic astrocytoma|2018|0.1|0.2|0.1
0-19|0.7|0.9|0.8|Malignant|337|41442486|Male|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549015|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42549015|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367323|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42367323|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42176956|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42176956|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42036128|Male|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42036128|Male|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41955322|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41955322|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|16|207689081|Male|Pineal parenchymal|2014-2018|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|93|207689081|Male|Pineal parenchymal|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41934839|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41934839|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41942505|Male|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41942505|Male|Pineal parenchymal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41921243|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|41921243|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41442486|Male|Pineal parenchymal|2018|~|~|~
0-19|~|~|~|Malignant|~|41442486|Male|Pineal parenchymal|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|123|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549015|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42367323|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367323|Male|Pituitary|2011|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|179|42176956|Male|Pituitary|2012|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Pituitary|2012|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|176|42036128|Male|Pituitary|2013|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|194|41955322|Male|Pituitary|2014|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41955322|Male|Pituitary|2014|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|940|207689081|Male|Pituitary|2014-2018|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|207689081|Male|Pituitary|2014-2018|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|163|41934839|Male|Pituitary|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Pituitary|2015|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|197|41942505|Male|Pituitary|2016|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41942505|Male|Pituitary|2016|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|223|41921243|Male|Pituitary|2017|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|41921243|Male|Pituitary|2017|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|168|41442486|Male|Pituitary|2018|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41442486|Male|Pituitary|2018|~|~|~
0-19|1.5|1.8|1.6|Benign/Borderline|688|41889233|Male|Total|2004|1.5|1.8|1.6
0-19|3.4|3.8|3.6|Malignant|1505|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.9|Benign/Borderline|788|42006384|Male|Total|2005|1.7|2.0|1.9
0-19|3.2|3.6|3.4|Malignant|1431|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|811|42158997|Male|Total|2006|1.8|2.1|1.9
0-19|3.4|3.8|3.6|Malignant|1513|42158997|Male|Total|2006|3.4|3.8|3.6
0-19|1.9|2.1|2.0|Benign/Borderline|853|42367071|Male|Total|2007|1.9|2.2|2.0
0-19|3.4|3.8|3.6|Malignant|1525|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.9|2.2|2.0|Benign/Borderline|867|42541971|Male|Total|2008|1.9|2.2|2.0
0-19|3.6|4.0|3.8|Malignant|1608|42541971|Male|Total|2008|3.6|4.0|3.8
0-19|2.1|2.4|2.2|Benign/Borderline|949|42609915|Male|Total|2009|2.1|2.4|2.2
0-19|3.5|3.9|3.7|Malignant|1557|42609915|Male|Total|2009|3.5|3.8|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|901|42549015|Male|Total|2010|2.0|2.3|2.1
0-19|3.6|4.0|3.8|Malignant|1607|42549015|Male|Total|2010|3.6|4.0|3.8
0-19|2.1|2.4|2.3|Benign/Borderline|961|42367323|Male|Total|2011|2.1|2.4|2.3
0-19|3.6|4.0|3.8|Malignant|1599|42367323|Male|Total|2011|3.6|4.0|3.8
0-19|2.3|2.6|2.4|Benign/Borderline|1016|42176956|Male|Total|2012|2.3|2.6|2.4
0-19|3.7|4.0|3.8|Malignant|1618|42176956|Male|Total|2012|3.7|4.0|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|1000|42036128|Male|Total|2013|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1598|42036128|Male|Total|2013|3.6|4.0|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|1004|41955322|Male|Total|2014|2.2|2.5|2.4
0-19|3.6|3.9|3.7|Malignant|1565|41955322|Male|Total|2014|3.5|3.9|3.7
0-19|2.4|2.5|2.5|Benign/Borderline|5154|207689081|Male|Total|2014-2018|2.4|2.6|2.5
0-19|3.6|3.7|3.7|Malignant|7576|207689081|Male|Total|2014-2018|3.6|3.7|3.6
0-19|2.2|2.5|2.4|Benign/Borderline|992|41934839|Male|Total|2015|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1598|41934839|Male|Total|2015|3.6|4.0|3.8
0-19|2.5|2.8|2.6|Benign/Borderline|1105|41942505|Male|Total|2016|2.5|2.8|2.6
0-19|3.5|3.9|3.7|Malignant|1563|41942505|Male|Total|2016|3.5|3.9|3.7
0-19|2.4|2.7|2.5|Benign/Borderline|1051|41921243|Male|Total|2017|2.4|2.7|2.5
0-19|3.8|4.1|4.0|Malignant|1654|41921243|Male|Total|2017|3.8|4.1|3.9
0-19|2.3|2.6|2.5|Benign/Borderline|1023|41442486|Male|Total|2018|2.3|2.6|2.5
0-19|2.9|3.2|3.0|Malignant|1254|41442486|Male|Total|2018|2.9|3.2|3.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|173|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42549015|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|42367323|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42176956|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|164|42036128|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|41955322|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|676|207689081|Male|Tumors of Cranial and Spinal Nerves|2014-2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|207689081|Male|Tumors of Cranial and Spinal Nerves|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|41934839|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|41942505|Male|Tumors of Cranial and Spinal Nerves|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|41921243|Male|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|41442486|Male|Tumors of Cranial and Spinal Nerves|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|233|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.6
0-19|3.1|3.5|3.3|Malignant|1363|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|261|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1297|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|260|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1363|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|269|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1377|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|281|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1445|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.6|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|275|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1413|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|286|42549015|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1451|42549015|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|310|42367323|Male|Tumors of Neuroepthelial Tissue|2011|0.7|0.8|0.7
0-19|3.3|3.6|3.5|Malignant|1462|42367323|Male|Tumors of Neuroepthelial Tissue|2011|3.3|3.6|3.5
0-19|0.7|0.8|0.8|Benign/Borderline|321|42176956|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.8|0.8
0-19|3.3|3.6|3.4|Malignant|1450|42176956|Male|Tumors of Neuroepthelial Tissue|2012|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|306|42036128|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1441|42036128|Male|Tumors of Neuroepthelial Tissue|2013|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|288|41955322|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1415|41955322|Male|Tumors of Neuroepthelial Tissue|2014|3.2|3.6|3.4
0-19|0.8|0.9|0.8|Benign/Borderline|1687|207689081|Male|Tumors of Neuroepthelial Tissue|2014-2018|0.8|0.9|0.8
0-19|3.2|3.4|3.3|Malignant|6817|207689081|Male|Tumors of Neuroepthelial Tissue|2014-2018|3.2|3.4|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|321|41934839|Male|Tumors of Neuroepthelial Tissue|2015|0.7|0.9|0.8
0-19|3.3|3.6|3.4|Malignant|1442|41934839|Male|Tumors of Neuroepthelial Tissue|2015|3.3|3.6|3.4
0-19|0.8|1.0|0.9|Benign/Borderline|360|41942505|Male|Tumors of Neuroepthelial Tissue|2016|0.8|1.0|0.9
0-19|3.2|3.5|3.3|Malignant|1403|41942505|Male|Tumors of Neuroepthelial Tissue|2016|3.2|3.5|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|335|41921243|Male|Tumors of Neuroepthelial Tissue|2017|0.7|0.9|0.8
0-19|3.3|3.7|3.5|Malignant|1476|41921243|Male|Tumors of Neuroepthelial Tissue|2017|3.3|3.7|3.5
0-19|0.9|1.0|0.9|Benign/Borderline|392|41442486|Male|Tumors of Neuroepthelial Tissue|2018|0.9|1.0|0.9
0-19|2.6|2.9|2.7|Malignant|1131|41442486|Male|Tumors of Neuroepthelial Tissue|2018|2.6|2.9|2.7
0-19|0.3|0.5|0.4|Benign/Borderline|171|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|217|42006384|Male|Tumors of Sellar Region|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|177|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|201|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|231|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|239|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|223|42549015|Male|Tumors of Sellar Region|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42367323|Male|Tumors of Sellar Region|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|258|42176956|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|269|42036128|Male|Tumors of Sellar Region|2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|300|41955322|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|1408|207689081|Male|Tumors of Sellar Region|2014-2018|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|207689081|Male|Tumors of Sellar Region|2014-2018|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|259|41934839|Male|Tumors of Sellar Region|2015|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|271|41942505|Male|Tumors of Sellar Region|2016|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of Sellar Region|2016|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|323|41921243|Male|Tumors of Sellar Region|2017|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of Sellar Region|2017|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|264|41442486|Male|Tumors of Sellar Region|2018|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of Sellar Region|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42367071|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42549015|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42549015|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|42367323|Male|Tumors of the Meninges|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42367323|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|42176956|Male|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42176956|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|108|42036128|Male|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42036128|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|41955322|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41955322|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|613|207689081|Male|Tumors of the Meninges|2014-2018|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|48|207689081|Male|Tumors of the Meninges|2014-2018|0.0|0.0|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|124|41934839|Male|Tumors of the Meninges|2015|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41934839|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|41942505|Male|Tumors of the Meninges|2016|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41942505|Male|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|41921243|Male|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41921243|Male|Tumors of the Meninges|2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|41442486|Male|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41442486|Male|Tumors of the Meninges|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|90|42158997|Male|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|153|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|135|42549015|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42549015|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|141|42367323|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|42367323|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|127|42176956|Male|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|42176956|Male|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|127|42036128|Male|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|42036128|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|128|41955322|Male|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41955322|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|637|207689081|Male|Unclassified Tumors|2014-2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|115|207689081|Male|Unclassified Tumors|2014-2018|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|41934839|Male|Unclassified Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|41934839|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|150|41942505|Male|Unclassified Tumors|2016|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|41942505|Male|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|129|41921243|Male|Unclassified Tumors|2017|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|30|41921243|Male|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|113|41442486|Male|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|41442486|Male|Unclassified Tumors|2018|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|31|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|41|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|43|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|42549015|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42549015|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|47|42367323|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42367323|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42176956|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42176956|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42036128|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42036128|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|44|41955322|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41955322|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|178|207689081|Male|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|117|207689081|Male|Unique astrocytoma variants|2014-2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|41934839|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41934839|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|37|41942505|Male|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41942505|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|41921243|Male|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41921243|Male|Unique astrocytoma variants|2017|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|41442486|Male|Unique astrocytoma variants|2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|22|41442486|Male|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83181748|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|All other|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|72|406542905|Male and Female|All other|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Malignant|300|406542905|Male and Female|All other|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82080244|Male and Female|All other|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|All other|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82106582|Male and Female|All other|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|81129651|Male and Female|All other|2018|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Malignant|236|81129651|Male and Female|All other|2018|0.3|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|87|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|76|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83181748|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82826880|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|68|82482164|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|96|82244884|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|98|82105856|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Anaplastic astrocytoma|2014-2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|370|406542905|Male and Female|Anaplastic astrocytoma|2014-2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|79|82080244|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|72|82106582|Male and Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|60|82062709|Male and Female|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|63|81129651|Male and Female|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|406542905|Male and Female|Anaplastic oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|178|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|206|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|83181748|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|185|82826880|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|165|82482164|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|193|82244884|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|82105856|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Astrocytoma, NOS|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|898|406542905|Male and Female|Astrocytoma, NOS|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|82080244|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|174|82106582|Male and Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|179|82062709|Male and Female|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|167|81129651|Male and Female|Astrocytoma, NOS|2018|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|83181748|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|83181748|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82826880|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82826880|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82482164|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82482164|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82244884|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82244884|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82105856|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82105856|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|313|406542905|Male and Female|Choroid plexus|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|101|406542905|Male and Female|Choroid plexus|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82080244|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|82080244|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82106582|Male and Female|Choroid plexus|2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82106582|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82062709|Male and Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82062709|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|81129651|Male and Female|Choroid plexus|2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|81129651|Male and Female|Choroid plexus|2018|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|162|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|175|83181748|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83181748|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82826880|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82482164|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82244884|Male and Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82244884|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|198|82105856|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|834|406542905|Male and Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|406542905|Male and Female|Craniopharyngioma|2014-2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|177|82080244|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|142|82106582|Male and Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82106582|Male and Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|179|82062709|Male and Female|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82062709|Male and Female|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|81129651|Male and Female|Craniopharyngioma|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Craniopharyngioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181748|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82826880|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82482164|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82244884|Male and Female|Diffuse astrocytoma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Diffuse astrocytoma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|406542905|Male and Female|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|509|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|498|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|519|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|489|83181748|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|497|82826880|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82482164|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|459|82244884|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|493|82105856|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
0-19|0.5|0.6|0.6|Malignant|2251|406542905|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.7|0.6|Malignant|489|82080244|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82106582|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.5|0.6|0.6|Malignant|470|82062709|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.5|0.4|Malignant|350|81129651|Male and Female|Embryonal/primitive/medulloblastoma|2018|0.4|0.5|0.4
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|83181748|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83181748|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82826880|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82826880|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82482164|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82482164|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82244884|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82244884|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|145|406542905|Male and Female|Ependymoma variants|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|406542905|Male and Female|Ependymoma variants|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82080244|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82080244|Male and Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82106582|Male and Female|Ependymoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82106582|Male and Female|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82062709|Male and Female|Ependymoma variants|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82062709|Male and Female|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|81129651|Male and Female|Ependymoma variants|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81129651|Male and Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|171|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83181748|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|213|82826880|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|82482164|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|204|82244884|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82105856|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|954|406542905|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|201|82080244|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|181|82106582|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|220|82062709|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|166|81129651|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|127|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|83181748|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|165|83181748|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82826880|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|82826880|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|82482164|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82482164|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|47|82244884|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|157|82244884|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|82105856|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|136|82105856|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|237|406542905|Male and Female|Germ Cell Tumors|2014-2018|0.1|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|752|406542905|Male and Female|Germ Cell Tumors|2014-2018|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82080244|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|152|82080244|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|60|82106582|Male and Female|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|168|82106582|Male and Female|Germ Cell Tumors|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82062709|Male and Female|Germ Cell Tumors|2017|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|173|82062709|Male and Female|Germ Cell Tumors|2017|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|54|81129651|Male and Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|127|81129651|Male and Female|Germ Cell Tumors|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|122|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|118|83181748|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|160|82826880|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|155|82482164|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|163|82244884|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|145|82105856|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Glioblastoma|2014-2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|698|406542905|Male and Female|Glioblastoma|2014-2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|150|82080244|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|138|82106582|Male and Female|Glioblastoma|2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|140|82062709|Male and Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|131|81129651|Male and Female|Glioblastoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|462|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|489|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|513|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|553|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|570|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|21|83181748|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|550|83181748|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82826880|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|595|82826880|Male and Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|34|82482164|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|508|82482164|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|32|82244884|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|577|82244884|Male and Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|40|82105856|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|535|82105856|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|226|406542905|Male and Female|Glioma malignant, NOS|2014-2018|0.0|0.1|0.1
0-19|0.7|0.7|0.7|Malignant|2784|406542905|Male and Female|Glioma malignant, NOS|2014-2018|0.7|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|38|82080244|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|582|82080244|Male and Female|Glioma malignant, NOS|2015|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|53|82106582|Male and Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|608|82106582|Male and Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|43|82062709|Male and Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.8|0.8|Malignant|632|82062709|Male and Female|Glioma malignant, NOS|2017|0.7|0.8|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|53|81129651|Male and Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Malignant|445|81129651|Male and Female|Glioma malignant, NOS|2018|0.5|0.6|0.5
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|83181748|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83181748|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82826880|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82826880|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82482164|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82482164|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82244884|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82244884|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|82105856|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82105856|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|191|406542905|Male and Female|Hemangioblastoma|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|406542905|Male and Female|Hemangioblastoma|2014-2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82080244|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82080244|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82106582|Male and Female|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82106582|Male and Female|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82062709|Male and Female|Hemangioblastoma|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82062709|Male and Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|81129651|Male and Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81129651|Male and Female|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|48|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|44|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|71|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|84|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|94|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|83181748|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|143|82826880|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|133|82482164|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|121|82244884|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82244884|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|124|82105856|Male and Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|596|406542905|Male and Female|Hemangioma|2014-2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|406542905|Male and Female|Hemangioma|2014-2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82080244|Male and Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82106582|Male and Female|Hemangioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82106582|Male and Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|82062709|Male and Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82062709|Male and Female|Hemangioma|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|81129651|Male and Female|Hemangioma|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81129651|Male and Female|Hemangioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|406542905|Male and Female|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82482164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|406542905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82080244|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82106582|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83181748|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82826880|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82826880|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82482164|Male and Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82482164|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|135|82244884|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82244884|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|130|82105856|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82105856|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|646|406542905|Male and Female|Meningioma|2014-2018|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|406542905|Male and Female|Meningioma|2014-2018|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|140|82080244|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82080244|Male and Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|82106582|Male and Female|Meningioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82106582|Male and Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82062709|Male and Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82062709|Male and Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|81129651|Male and Female|Meningioma|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Meningioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83181748|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82826880|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82482164|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82244884|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82105856|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Mixed glioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|51|406542905|Male and Female|Mixed glioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Mixed glioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|114|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|105|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|117|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|128|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|153|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|83181748|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83181748|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|138|82826880|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82826880|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|134|82482164|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|53|82482164|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|143|82244884|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82244884|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|150|82105856|Male and Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82105856|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|652|406542905|Male and Female|Neoplasm, unspecified|2014-2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|213|406542905|Male and Female|Neoplasm, unspecified|2014-2018|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|143|82080244|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82080244|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|120|82106582|Male and Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|46|82106582|Male and Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|118|82062709|Male and Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82062709|Male and Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|124|81129651|Male and Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|43|81129651|Male and Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|241|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|289|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|330|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|312|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|83181748|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181748|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|283|82826880|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82826880|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|301|82482164|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82482164|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|315|82244884|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82244884|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|254|82105856|Male and Female|Nerve sheath, benign and malignant|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82105856|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1257|406542905|Male and Female|Nerve sheath, benign and malignant|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|406542905|Male and Female|Nerve sheath, benign and malignant|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|310|82080244|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82080244|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|305|82106582|Male and Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82106582|Male and Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|233|82062709|Male and Female|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82062709|Male and Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|81129651|Male and Female|Nerve sheath, benign and malignant|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83181748|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82826880|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82482164|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82244884|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82105856|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Neuroepithelial|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|40|406542905|Male and Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82080244|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|82106582|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|82062709|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|81129651|Male and Female|Neuroepithelial|2018|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|265|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|282|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|312|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|312|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|297|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|83181748|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83181748|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|344|82826880|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|36|82826880|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|361|82482164|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|37|82482164|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|351|82244884|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|46|82244884|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|333|82105856|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|56|82105856|Male and Female|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|1862|406542905|Male and Female|Neuronal/glial, neuronal|2014-2018|0.4|0.5|0.5
0-19|0.1|0.1|0.1|Malignant|240|406542905|Male and Female|Neuronal/glial, neuronal|2014-2018|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|386|82080244|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|42|82080244|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|412|82106582|Male and Female|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.1|0.1|0.1|Malignant|55|82106582|Male and Female|Neuronal/glial, neuronal|2016|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|397|82062709|Male and Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|39|82062709|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|345|81129651|Male and Female|Neuronal/glial, neuronal|2018|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|50|81129651|Male and Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83181748|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82826880|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|82482164|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82244884|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82105856|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|406542905|Male and Female|Oligodendroglioma|2014-2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|161|406542905|Male and Female|Oligodendroglioma|2014-2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82080244|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82106582|Male and Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Oligodendroglioma|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82062709|Male and Female|Oligodendroglioma|2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Oligodendroglioma|2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|81129651|Male and Female|Oligodendroglioma|2018|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|27|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|83181748|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83181748|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|61|82826880|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82826880|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82482164|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82482164|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|75|82244884|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82244884|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|76|82105856|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82105856|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|438|406542905|Male and Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|64|406542905|Male and Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|85|82080244|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82080244|Male and Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|101|82106582|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82106582|Male and Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|92|82062709|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82062709|Male and Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|84|81129651|Male and Female|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81129651|Male and Female|Other mesenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|700|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|675|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|687|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|732|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|721|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|775|83181748|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|755|82826880|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|807|82482164|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|1.0|Malignant|799|82244884|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|1.0|Malignant|788|82105856|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|1.0
0-19|0.0|0.0|0.0|Benign/Borderline|132|406542905|Male and Female|Pilocytic astrocytoma|2014-2018|0.0|0.0|0.0
0-19|0.9|0.9|0.9|Malignant|3715|406542905|Male and Female|Pilocytic astrocytoma|2014-2018|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|739|82080244|Male and Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|0.9|0.9|Malignant|707|82106582|Male and Female|Pilocytic astrocytoma|2016|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Pilocytic astrocytoma|2017|~|~|~
0-19|1.0|1.1|1.0|Malignant|838|82062709|Male and Female|Pilocytic astrocytoma|2017|1.0|1.1|1.0
0-19|0.1|0.2|0.2|Benign/Borderline|132|81129651|Male and Female|Pilocytic astrocytoma|2018|0.1|0.2|0.2
0-19|0.8|0.9|0.8|Malignant|666|81129651|Male and Female|Pilocytic astrocytoma|2018|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181748|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83181748|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82826880|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82826880|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82482164|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82482164|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82244884|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|82244884|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82105856|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82105856|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|36|406542905|Male and Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|179|406542905|Male and Female|Pineal parenchymal|2014-2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82080244|Male and Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82080244|Male and Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82106582|Male and Female|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82106582|Male and Female|Pineal parenchymal|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82062709|Male and Female|Pineal parenchymal|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82062709|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81129651|Male and Female|Pineal parenchymal|2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81129651|Male and Female|Pineal parenchymal|2018|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|363|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|441|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|459|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|462|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|539|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|562|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|606|83181748|Male and Female|Pituitary|2010|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83181748|Male and Female|Pituitary|2010|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|619|82826880|Male and Female|Pituitary|2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82826880|Male and Female|Pituitary|2011|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|682|82482164|Male and Female|Pituitary|2012|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82482164|Male and Female|Pituitary|2012|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|659|82244884|Male and Female|Pituitary|2013|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|82244884|Male and Female|Pituitary|2013|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|726|82105856|Male and Female|Pituitary|2014|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82105856|Male and Female|Pituitary|2014|~|~|~
0-19|0.9|0.9|0.9|Benign/Borderline|3621|406542905|Male and Female|Pituitary|2014-2018|0.9|0.9|0.9
0-19|~|~|~|Malignant|~|406542905|Male and Female|Pituitary|2014-2018|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|686|82080244|Male and Female|Pituitary|2015|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82080244|Male and Female|Pituitary|2015|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|761|82106582|Male and Female|Pituitary|2016|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82106582|Male and Female|Pituitary|2016|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|786|82062709|Male and Female|Pituitary|2017|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82062709|Male and Female|Pituitary|2017|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|682|81129651|Male and Female|Pituitary|2018|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|81129651|Male and Female|Pituitary|2018|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|1487|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.5|Malignant|2812|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1753|82005260|Male and Female|Total|2005|2.0|2.2|2.1
0-19|3.1|3.4|3.3|Malignant|2670|82005260|Male and Female|Total|2005|3.1|3.4|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1792|82324418|Male and Female|Total|2006|2.1|2.3|2.2
0-19|3.2|3.5|3.3|Malignant|2741|82324418|Male and Female|Total|2006|3.2|3.5|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1846|82749431|Male and Female|Total|2007|2.1|2.3|2.2
0-19|3.3|3.6|3.4|Malignant|2827|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1949|83118264|Male and Female|Total|2008|2.2|2.5|2.3
0-19|3.4|3.6|3.5|Malignant|2896|83118264|Male and Female|Total|2008|3.4|3.6|3.5
0-19|2.3|2.5|2.4|Benign/Borderline|2052|83280391|Male and Female|Total|2009|2.4|2.6|2.5
0-19|3.3|3.6|3.4|Malignant|2856|83280391|Male and Female|Total|2009|3.3|3.6|3.4
0-19|2.4|2.6|2.5|Benign/Borderline|2081|83181748|Male and Female|Total|2010|2.4|2.6|2.5
0-19|3.4|3.6|3.5|Malignant|2914|83181748|Male and Female|Total|2010|3.4|3.6|3.5
0-19|2.5|2.7|2.6|Benign/Borderline|2176|82826880|Male and Female|Total|2011|2.5|2.7|2.6
0-19|3.4|3.7|3.6|Malignant|2952|82826880|Male and Female|Total|2011|3.4|3.7|3.6
0-19|2.6|2.9|2.7|Benign/Borderline|2282|82482164|Male and Female|Total|2012|2.7|2.9|2.8
0-19|3.3|3.6|3.5|Malignant|2857|82482164|Male and Female|Total|2012|3.3|3.6|3.5
0-19|2.7|2.9|2.8|Benign/Borderline|2287|82244884|Male and Female|Total|2013|2.7|2.9|2.8
0-19|3.5|3.7|3.6|Malignant|2960|82244884|Male and Female|Total|2013|3.5|3.7|3.6
0-19|2.7|2.9|2.8|Benign/Borderline|2299|82105856|Male and Female|Total|2014|2.7|2.9|2.8
0-19|3.5|3.7|3.6|Malignant|2948|82105856|Male and Female|Total|2014|3.5|3.7|3.6
0-19|2.8|2.9|2.8|Benign/Borderline|11509|406542905|Male and Female|Total|2014-2018|2.8|2.9|2.8
0-19|3.4|3.5|3.4|Malignant|13900|406542905|Male and Female|Total|2014-2018|3.4|3.5|3.4
0-19|2.7|2.9|2.8|Benign/Borderline|2317|82080244|Male and Female|Total|2015|2.7|2.9|2.8
0-19|3.4|3.6|3.5|Malignant|2885|82080244|Male and Female|Total|2015|3.4|3.6|3.5
0-19|2.8|3.0|2.9|Benign/Borderline|2417|82106582|Male and Female|Total|2016|2.8|3.1|2.9
0-19|3.3|3.6|3.5|Malignant|2835|82106582|Male and Female|Total|2016|3.3|3.6|3.5
0-19|2.7|2.9|2.8|Benign/Borderline|2321|82062709|Male and Female|Total|2017|2.7|2.9|2.8
0-19|3.5|3.8|3.6|Malignant|2970|82062709|Male and Female|Total|2017|3.5|3.8|3.6
0-19|2.6|2.8|2.7|Benign/Borderline|2216|81129651|Male and Female|Total|2018|2.6|2.8|2.7
0-19|2.8|3.0|2.9|Malignant|2370|81129651|Male and Female|Total|2018|2.8|3.0|2.9
0-19|0.3|0.3|0.3|Benign/Borderline|241|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|289|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|330|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|312|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|83181748|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181748|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|283|82826880|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82826880|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|301|82482164|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82482164|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|316|82244884|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82244884|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|256|82105856|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82105856|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1259|406542905|Male and Female|Tumors of Cranial and Spinal Nerves|2014-2018|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|406542905|Male and Female|Tumors of Cranial and Spinal Nerves|2014-2018|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|310|82080244|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82080244|Male and Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|305|82106582|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82106582|Male and Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|233|82062709|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82062709|Male and Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|81129651|Male and Female|Tumors of Cranial and Spinal Nerves|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81129651|Male and Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|424|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2572|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|459|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2445|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|464|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2521|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|498|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2616|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|510|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|2678|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|490|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.1|3.3|3.2|Malignant|2632|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|519|83181748|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|2677|83181748|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|558|82826880|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2736|82826880|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|575|82482164|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.1|3.3|3.2|Malignant|2626|82482164|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.1|3.3|3.2
0-19|0.6|0.8|0.7|Benign/Borderline|570|82244884|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.2|3.4|3.3|Malignant|2714|82244884|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.2|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|539|82105856|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2724|82105856|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.2|3.4|3.3
0-19|0.7|0.8|0.7|Benign/Borderline|3033|406542905|Male and Female|Tumors of Neuroepthelial Tissue|2014-2018|0.7|0.8|0.7
0-19|3.1|3.2|3.1|Malignant|12730|406542905|Male and Female|Tumors of Neuroepthelial Tissue|2014-2018|3.1|3.2|3.1
0-19|0.6|0.8|0.7|Benign/Borderline|575|82080244|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.8|0.7
0-19|3.1|3.4|3.2|Malignant|2646|82080244|Male and Female|Tumors of Neuroepthelial Tissue|2015|3.1|3.3|3.2
0-19|0.7|0.8|0.8|Benign/Borderline|637|82106582|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.7|0.8|0.8
0-19|3.0|3.3|3.1|Malignant|2572|82106582|Male and Female|Tumors of Neuroepthelial Tissue|2016|3.0|3.3|3.1
0-19|0.7|0.8|0.7|Benign/Borderline|603|82062709|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.7|0.8|0.7
0-19|3.2|3.4|3.3|Malignant|2714|82062709|Male and Female|Tumors of Neuroepthelial Tissue|2017|3.2|3.4|3.3
0-19|0.8|0.9|0.9|Benign/Borderline|700|81129651|Male and Female|Tumors of Neuroepthelial Tissue|2018|0.8|0.9|0.9
0-19|2.6|2.8|2.7|Malignant|2169|81129651|Male and Female|Tumors of Neuroepthelial Tissue|2018|2.6|2.8|2.7
0-19|0.6|0.7|0.6|Benign/Borderline|532|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|613|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|617|82324418|Male and Female|Tumors of Sellar Region|2006|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|644|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|701|83118264|Male and Female|Tumors of Sellar Region|2008|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|734|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|781|83181748|Male and Female|Tumors of Sellar Region|2010|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|83181748|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|777|82826880|Male and Female|Tumors of Sellar Region|2011|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82826880|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|839|82482164|Male and Female|Tumors of Sellar Region|2012|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82482164|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|841|82244884|Male and Female|Tumors of Sellar Region|2013|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|82244884|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|924|82105856|Male and Female|Tumors of Sellar Region|2014|1.1|1.2|1.1
0-19|~|~|~|Malignant|~|82105856|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.1|1.1|1.1|Benign/Borderline|4455|406542905|Male and Female|Tumors of Sellar Region|2014-2018|1.1|1.1|1.1
0-19|~|~|~|Malignant|~|406542905|Male and Female|Tumors of Sellar Region|2014-2018|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|863|82080244|Male and Female|Tumors of Sellar Region|2015|1.0|1.1|1.1
0-19|~|~|~|Malignant|~|82080244|Male and Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|903|82106582|Male and Female|Tumors of Sellar Region|2016|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|82106582|Male and Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.1|1.2|1.2|Benign/Borderline|965|82062709|Male and Female|Tumors of Sellar Region|2017|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|82062709|Male and Female|Tumors of Sellar Region|2017|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|829|81129651|Male and Female|Tumors of Sellar Region|2018|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|81129651|Male and Female|Tumors of Sellar Region|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|198|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|159|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|176|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|181|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|200|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|22|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|194|83181748|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83181748|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|239|82826880|Male and Female|Tumors of the Meninges|2011|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82826880|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|261|82482164|Male and Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|20|82482164|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|247|82244884|Male and Female|Tumors of the Meninges|2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82244884|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|258|82105856|Male and Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|18|82105856|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1275|406542905|Male and Female|Tumors of the Meninges|2014-2018|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|94|406542905|Male and Female|Tumors of the Meninges|2014-2018|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|259|82080244|Male and Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|23|82080244|Male and Female|Tumors of the Meninges|2015|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|255|82106582|Male and Female|Tumors of the Meninges|2016|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|22|82106582|Male and Female|Tumors of the Meninges|2016|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|82062709|Male and Female|Tumors of the Meninges|2017|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82062709|Male and Female|Tumors of the Meninges|2017|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|255|81129651|Male and Female|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|81129651|Male and Female|Tumors of the Meninges|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|111|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|158|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|176|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|201|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|222|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|268|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|268|83181748|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83181748|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|281|82826880|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|36|82826880|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|267|82482164|Male and Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|56|82482164|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|265|82244884|Male and Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|43|82244884|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|274|82105856|Male and Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|82105856|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|1250|406542905|Male and Female|Unclassified Tumors|2014-2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|224|406542905|Male and Female|Unclassified Tumors|2014-2018|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|273|82080244|Male and Female|Unclassified Tumors|2015|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|38|82080244|Male and Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|257|82106582|Male and Female|Unclassified Tumors|2016|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|47|82106582|Male and Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|230|82062709|Male and Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|52|82062709|Male and Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|222|81129651|Male and Female|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|46|81129651|Male and Female|Unclassified Tumors|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|53|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|67|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|61|83181748|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83181748|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82826880|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|51|82826880|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|74|82482164|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|45|82482164|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|75|82244884|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|82244884|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|85|82105856|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82105856|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|299|406542905|Male and Female|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|225|406542905|Male and Female|Unique astrocytoma variants|2014-2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|46|82080244|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|52|82080244|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|58|82106582|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|47|82106582|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|53|82062709|Male and Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82062709|Male and Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|61|81129651|Male and Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|45|81129651|Male and Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|116614175|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|116614175|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117897259|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|117897259|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|119151385|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119151385|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|120303033|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120303033|Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|121496050|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|121496050|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|141|612963903|Female|All other|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|268|612963903|Female|All other|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|122633364|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|122633364|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|123755449|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|123755449|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|124798153|Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|124798153|Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|124605782|Female|All other|2018|0.0|0.0|0.0
20+|0.1|0.2|0.1|Malignant|164|124605782|Female|All other|2018|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|512|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|529|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|503|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|501|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116614175|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|573|116614175|Female|Anaplastic astrocytoma|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117897259|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|570|117897259|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119151385|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|588|119151385|Female|Anaplastic astrocytoma|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120303033|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|641|120303033|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|121496050|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.5|0.5|0.5|Malignant|615|121496050|Female|Anaplastic astrocytoma|2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|612963903|Female|Anaplastic astrocytoma|2014-2018|~|~|~
20+|0.5|0.5|0.5|Malignant|3215|612963903|Female|Anaplastic astrocytoma|2014-2018|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|122633364|Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|700|122633364|Female|Anaplastic astrocytoma|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|123755449|Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|641|123755449|Female|Anaplastic astrocytoma|2016|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|124798153|Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.5|0.6|0.5|Malignant|669|124798153|Female|Anaplastic astrocytoma|2017|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|124605782|Female|Anaplastic astrocytoma|2018|~|~|~
20+|0.4|0.5|0.5|Malignant|609|124605782|Female|Anaplastic astrocytoma|2018|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|185|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.2|Malignant|167|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|137|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|161|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|171|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|146|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116614175|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|135|116614175|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117897259|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|153|117897259|Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119151385|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|169|119151385|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120303033|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|154|120303033|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121496050|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|153|121496050|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|612963903|Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|814|612963903|Female|Anaplastic oligodendroglioma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122633364|Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|164|122633364|Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|123755449|Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|168|123755449|Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|124798153|Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.1|0.2|0.1|Malignant|183|124798153|Female|Anaplastic oligodendroglioma|2017|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|124605782|Female|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|150|124605782|Female|Anaplastic oligodendroglioma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|571|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|565|110320645|Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|540|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|535|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|495|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|482|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116614175|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|478|116614175|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117897259|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|462|117897259|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119151385|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|491|119151385|Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|120303033|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|448|120303033|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121496050|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.4|0.4|Malignant|490|121496050|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|612963903|Female|Astrocytoma, NOS|2014-2018|~|~|~
20+|0.4|0.4|0.4|Malignant|2639|612963903|Female|Astrocytoma, NOS|2014-2018|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|122633364|Female|Astrocytoma, NOS|2015|~|~|~
20+|0.4|0.5|0.4|Malignant|516|122633364|Female|Astrocytoma, NOS|2015|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|123755449|Female|Astrocytoma, NOS|2016|~|~|~
20+|0.4|0.5|0.4|Malignant|565|123755449|Female|Astrocytoma, NOS|2016|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|124798153|Female|Astrocytoma, NOS|2017|~|~|~
20+|0.4|0.4|0.4|Malignant|505|124798153|Female|Astrocytoma, NOS|2017|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|124605782|Female|Astrocytoma, NOS|2018|~|~|~
20+|0.4|0.5|0.5|Malignant|573|124605782|Female|Astrocytoma, NOS|2018|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|116614175|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116614175|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|52|117897259|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|117897259|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|40|119151385|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119151385|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|120303033|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120303033|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|121496050|Female|Choroid plexus|2014|0.0|0.1|0.0
20+|~|~|~|Malignant|~|121496050|Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|231|612963903|Female|Choroid plexus|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|612963903|Female|Choroid plexus|2014-2018|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|122633364|Female|Choroid plexus|2015|0.0|0.1|0.0
20+|~|~|~|Malignant|~|122633364|Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|123755449|Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123755449|Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|42|124798153|Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124798153|Female|Choroid plexus|2017|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|56|124605782|Female|Choroid plexus|2018|0.0|0.1|0.0
20+|~|~|~|Malignant|~|124605782|Female|Choroid plexus|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|205|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|185|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|116614175|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116614175|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|117897259|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117897259|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|119151385|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119151385|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|244|120303033|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120303033|Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|121496050|Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121496050|Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1152|612963903|Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|612963903|Female|Craniopharyngioma|2014-2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|122633364|Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122633364|Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|123755449|Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123755449|Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|244|124798153|Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124798153|Female|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|124605782|Female|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124605782|Female|Craniopharyngioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116614175|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|163|116614175|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117897259|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|114|117897259|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119151385|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119151385|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120303033|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|71|120303033|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121496050|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|63|121496050|Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|612963903|Female|Diffuse astrocytoma|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|128|612963903|Female|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122633364|Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122633364|Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123755449|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Malignant|~|123755449|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|124798153|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|124798153|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124605782|Female|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Malignant|~|124605782|Female|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116614175|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116614175|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117897259|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|117897259|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119151385|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|119151385|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120303033|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|89|120303033|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121496050|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|73|121496050|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|612963903|Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
20+|0.0|0.1|0.1|Malignant|320|612963903|Female|Embryonal/primitive/medulloblastoma|2014-2018|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122633364|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.0|0.1|0.1|Malignant|68|122633364|Female|Embryonal/primitive/medulloblastoma|2015|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123755449|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|63|123755449|Female|Embryonal/primitive/medulloblastoma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124798153|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.0|0.1|0.1|Malignant|63|124798153|Female|Embryonal/primitive/medulloblastoma|2017|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124605782|Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.0|0.1|0.0|Malignant|57|124605782|Female|Embryonal/primitive/medulloblastoma|2018|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116614175|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116614175|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|117897259|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117897259|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|130|119151385|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119151385|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|120303033|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120303033|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|131|121496050|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121496050|Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|610|612963903|Female|Ependymoma variants|2014-2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|612963903|Female|Ependymoma variants|2014-2018|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|135|122633364|Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|122633364|Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|124|123755449|Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|123755449|Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|116|124798153|Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|124798153|Female|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|110|124605782|Female|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|124605782|Female|Ependymoma variants|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|293|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|303|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|295|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|297|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|313|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|346|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116614175|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|296|116614175|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117897259|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|298|117897259|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119151385|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|303|119151385|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120303033|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|278|120303033|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|121496050|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|243|121496050|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|51|612963903|Female|Ependymoma/anaplastic ependymoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|1294|612963903|Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122633364|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.2|Malignant|275|122633364|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|123755449|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.2|Malignant|272|123755449|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|124798153|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|285|124798153|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|124605782|Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
20+|0.2|0.2|0.2|Malignant|224|124605782|Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116614175|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116614175|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|117897259|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117897259|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|119151385|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119151385|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|120303033|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120303033|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|121496050|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121496050|Female|Germ Cell Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|131|612963903|Female|Germ Cell Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|612963903|Female|Germ Cell Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|122633364|Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122633364|Female|Germ Cell Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|123755449|Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123755449|Female|Germ Cell Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|124798153|Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124798153|Female|Germ Cell Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|124605782|Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124605782|Female|Germ Cell Tumors|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4095|109112165|Female|Glioblastoma|2004|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4161|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4290|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4373|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4404|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4483|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116614175|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4620|116614175|Female|Glioblastoma|2010|3.8|4.1|4.0
20+|~|~|~|Benign/Borderline|~|117897259|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4588|117897259|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|119151385|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4866|119151385|Female|Glioblastoma|2012|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|120303033|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4920|120303033|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121496050|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4796|121496050|Female|Glioblastoma|2014|3.8|4.1|3.9
20+|~|~|~|Benign/Borderline|~|612963903|Female|Glioblastoma|2014-2018|~|~|~
20+|3.4|3.5|3.5|Malignant|25297|612963903|Female|Glioblastoma|2014-2018|4.1|4.2|4.1
20+|~|~|~|Benign/Borderline|~|122633364|Female|Glioblastoma|2015|~|~|~
20+|3.5|3.7|3.6|Malignant|5133|122633364|Female|Glioblastoma|2015|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|123755449|Female|Glioblastoma|2016|~|~|~
20+|3.5|3.7|3.6|Malignant|5213|123755449|Female|Glioblastoma|2016|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|124798153|Female|Glioblastoma|2017|~|~|~
20+|3.4|3.6|3.5|Malignant|5208|124798153|Female|Glioblastoma|2017|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|124605782|Female|Glioblastoma|2018|~|~|~
20+|3.3|3.5|3.4|Malignant|5144|124605782|Female|Glioblastoma|2018|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|426|109112165|Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|393|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|400|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|413|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|445|114027722|Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|514|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116614175|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|410|116614175|Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117897259|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|451|117897259|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|119151385|Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|438|119151385|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|120303033|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|461|120303033|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|121496050|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|449|121496050|Female|Glioma malignant, NOS|2014|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|124|612963903|Female|Glioma malignant, NOS|2014-2018|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2493|612963903|Female|Glioma malignant, NOS|2014-2018|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|122633364|Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|522|122633364|Female|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|22|123755449|Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|528|123755449|Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|124798153|Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|541|124798153|Female|Glioma malignant, NOS|2017|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|124605782|Female|Glioma malignant, NOS|2018|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|466|124605782|Female|Glioma malignant, NOS|2018|0.3|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|207|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|116614175|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116614175|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|248|117897259|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117897259|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|260|119151385|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119151385|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|236|120303033|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120303033|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|121496050|Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121496050|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1152|612963903|Female|Hemangioblastoma|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|16|612963903|Female|Hemangioblastoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|245|122633364|Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122633364|Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|266|123755449|Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123755449|Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|124798153|Female|Hemangioblastoma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124798153|Female|Hemangioblastoma|2017|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|210|124605782|Female|Hemangioblastoma|2018|0.1|0.2|0.2
20+|~|~|~|Malignant|~|124605782|Female|Hemangioblastoma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|240|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|287|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|320|111567226|Female|Hemangioma|2006|0.3|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|372|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|473|114027722|Female|Hemangioma|2008|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|529|115293599|Female|Hemangioma|2009|0.4|0.5|0.5
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|661|116614175|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116614175|Female|Hemangioma|2010|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|717|117897259|Female|Hemangioma|2011|0.6|0.7|0.6
20+|~|~|~|Malignant|~|117897259|Female|Hemangioma|2011|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|723|119151385|Female|Hemangioma|2012|0.6|0.7|0.6
20+|~|~|~|Malignant|~|119151385|Female|Hemangioma|2012|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|729|120303033|Female|Hemangioma|2013|0.6|0.7|0.6
20+|~|~|~|Malignant|~|120303033|Female|Hemangioma|2013|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|666|121496050|Female|Hemangioma|2014|0.5|0.6|0.5
20+|~|~|~|Malignant|~|121496050|Female|Hemangioma|2014|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|2769|612963903|Female|Hemangioma|2014-2018|0.4|0.5|0.5
20+|~|~|~|Malignant|~|612963903|Female|Hemangioma|2014-2018|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|580|122633364|Female|Hemangioma|2015|0.4|0.5|0.5
20+|~|~|~|Malignant|~|122633364|Female|Hemangioma|2015|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|550|123755449|Female|Hemangioma|2016|0.4|0.5|0.4
20+|~|~|~|Malignant|~|123755449|Female|Hemangioma|2016|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|507|124798153|Female|Hemangioma|2017|0.4|0.4|0.4
20+|~|~|~|Malignant|~|124798153|Female|Hemangioma|2017|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|477|124605782|Female|Hemangioma|2018|0.3|0.4|0.4
20+|~|~|~|Malignant|~|124605782|Female|Hemangioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116614175|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|116614175|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117897259|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117897259|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119151385|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119151385|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120303033|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Malignant|~|120303033|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|121496050|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|121496050|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|612963903|Female|Local Extensions from Regional Tumors|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|84|612963903|Female|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122633364|Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|19|122633364|Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123755449|Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|16|123755449|Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124798153|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Malignant|~|124798153|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124605782|Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|~|~|~|Malignant|~|124605782|Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|592|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|662|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|674|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|640|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|702|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|667|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116614175|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|750|116614175|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|117897259|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|717|117897259|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|119151385|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|707|119151385|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120303033|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|740|120303033|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121496050|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|815|121496050|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|612963903|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
20+|0.5|0.6|0.6|Malignant|4027|612963903|Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|122633364|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|760|122633364|Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|123755449|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|833|123755449|Female|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|124798153|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|830|124798153|Female|Lymphomas and Hematopoietic Neoplasms|2017|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|124605782|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.5|0.6|0.5|Malignant|811|124605782|Female|Lymphomas and Hematopoietic Neoplasms|2018|0.6|0.7|0.7
20+|12.1|12.5|12.3|Benign/Borderline|14236|109112165|Female|Meningioma|2004|12.8|13.3|13.0
20+|0.2|0.3|0.2|Malignant|274|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.6|14.0|13.8|Benign/Borderline|16305|110320645|Female|Meningioma|2005|14.6|15.0|14.8
20+|0.2|0.3|0.2|Malignant|280|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|14.2|14.7|14.4|Benign/Borderline|17359|111567226|Female|Meningioma|2006|15.3|15.8|15.6
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.8|15.2|15.0|Benign/Borderline|18303|112783993|Female|Meningioma|2007|16.0|16.5|16.2
20+|0.2|0.2|0.2|Malignant|270|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.5|16.0|15.8|Benign/Borderline|19604|114027722|Female|Meningioma|2008|17.0|17.4|17.2
20+|0.2|0.2|0.2|Malignant|218|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|16.6|17.0|16.8|Benign/Borderline|21264|115293599|Female|Meningioma|2009|18.2|18.7|18.4
20+|0.1|0.2|0.2|Malignant|202|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|16.0|16.5|16.2|Benign/Borderline|20874|116614175|Female|Meningioma|2010|17.7|18.1|17.9
20+|0.1|0.2|0.2|Malignant|207|116614175|Female|Meningioma|2010|0.2|0.2|0.2
20+|16.1|16.6|16.4|Benign/Borderline|21298|117897259|Female|Meningioma|2011|17.8|18.3|18.1
20+|0.1|0.2|0.1|Malignant|186|117897259|Female|Meningioma|2011|0.1|0.2|0.2
20+|16.4|16.9|16.7|Benign/Borderline|22107|119151385|Female|Meningioma|2012|18.3|18.8|18.6
20+|0.1|0.2|0.2|Malignant|202|119151385|Female|Meningioma|2012|0.1|0.2|0.2
20+|16.6|17.0|16.8|Benign/Borderline|22579|120303033|Female|Meningioma|2013|18.5|19.0|18.8
20+|0.1|0.2|0.2|Malignant|227|120303033|Female|Meningioma|2013|0.2|0.2|0.2
20+|16.9|17.3|17.1|Benign/Borderline|23448|121496050|Female|Meningioma|2014|19.1|19.5|19.3
20+|0.1|0.2|0.2|Malignant|216|121496050|Female|Meningioma|2014|0.2|0.2|0.2
20+|17.4|17.6|17.5|Benign/Borderline|122639|612963903|Female|Meningioma|2014-2018|19.9|20.1|20.0
20+|0.1|0.1|0.1|Malignant|925|612963903|Female|Meningioma|2014-2018|0.1|0.2|0.2
20+|17.3|17.8|17.5|Benign/Borderline|24460|122633364|Female|Meningioma|2015|19.7|20.2|19.9
20+|0.1|0.2|0.1|Malignant|200|122633364|Female|Meningioma|2015|0.1|0.2|0.2
20+|17.5|18.0|17.8|Benign/Borderline|25081|123755449|Female|Meningioma|2016|20.0|20.5|20.3
20+|0.1|0.1|0.1|Malignant|171|123755449|Female|Meningioma|2016|0.1|0.2|0.1
20+|17.6|18.0|17.8|Benign/Borderline|25653|124798153|Female|Meningioma|2017|20.3|20.8|20.6
20+|0.1|0.1|0.1|Malignant|176|124798153|Female|Meningioma|2017|0.1|0.2|0.1
20+|16.8|17.3|17.1|Benign/Borderline|24756|124605782|Female|Meningioma|2018|19.6|20.1|19.9
20+|0.1|0.1|0.1|Malignant|169|124605782|Female|Meningioma|2018|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|239|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|287|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116614175|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|271|116614175|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|117897259|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|272|117897259|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119151385|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|243|119151385|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120303033|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|248|120303033|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121496050|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|200|121496050|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|612963903|Female|Mixed glioma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|415|612963903|Female|Mixed glioma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122633364|Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|131|122633364|Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123755449|Female|Mixed glioma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|43|123755449|Female|Mixed glioma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124798153|Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|31|124798153|Female|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124605782|Female|Mixed glioma|2018|~|~|~
20+|~|~|~|Malignant|~|124605782|Female|Mixed glioma|2018|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|689|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|703|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|871|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|719|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|805|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|721|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|836|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|652|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|836|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|753|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|922|115293599|Female|Neoplasm, unspecified|2009|0.7|0.9|0.8
20+|0.5|0.6|0.6|Malignant|783|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|827|116614175|Female|Neoplasm, unspecified|2010|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|647|116614175|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|849|117897259|Female|Neoplasm, unspecified|2011|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|645|117897259|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|876|119151385|Female|Neoplasm, unspecified|2012|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|653|119151385|Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|797|120303033|Female|Neoplasm, unspecified|2013|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|665|120303033|Female|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|878|121496050|Female|Neoplasm, unspecified|2014|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|738|121496050|Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.6|Benign/Borderline|3886|612963903|Female|Neoplasm, unspecified|2014-2018|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|3356|612963903|Female|Neoplasm, unspecified|2014-2018|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|847|122633364|Female|Neoplasm, unspecified|2015|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|729|122633364|Female|Neoplasm, unspecified|2015|0.6|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|775|123755449|Female|Neoplasm, unspecified|2016|0.6|0.7|0.6
20+|0.4|0.4|0.4|Malignant|610|123755449|Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.5|0.6|0.5|Benign/Borderline|743|124798153|Female|Neoplasm, unspecified|2017|0.6|0.6|0.6
20+|0.4|0.5|0.4|Malignant|673|124798153|Female|Neoplasm, unspecified|2017|0.5|0.6|0.5
20+|0.4|0.5|0.5|Benign/Borderline|657|124605782|Female|Neoplasm, unspecified|2018|0.5|0.6|0.5
20+|0.4|0.4|0.4|Malignant|633|124605782|Female|Neoplasm, unspecified|2018|0.5|0.5|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2572|109112165|Female|Nerve sheath, benign and malignant|2004|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2844|110320645|Female|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2973|111567226|Female|Nerve sheath, benign and malignant|2006|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2978|112783993|Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3101|114027722|Female|Nerve sheath, benign and malignant|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3259|115293599|Female|Nerve sheath, benign and malignant|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3067|116614175|Female|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116614175|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3321|117897259|Female|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117897259|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|3517|119151385|Female|Nerve sheath, benign and malignant|2012|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|26|119151385|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3689|120303033|Female|Nerve sheath, benign and malignant|2013|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|120303033|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3809|121496050|Female|Nerve sheath, benign and malignant|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|17|121496050|Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|18507|612963903|Female|Nerve sheath, benign and malignant|2014-2018|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|98|612963903|Female|Nerve sheath, benign and malignant|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3882|122633364|Female|Nerve sheath, benign and malignant|2015|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|23|122633364|Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3807|123755449|Female|Nerve sheath, benign and malignant|2016|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|26|123755449|Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3675|124798153|Female|Nerve sheath, benign and malignant|2017|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|18|124798153|Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3409|124605782|Female|Nerve sheath, benign and malignant|2018|2.6|2.8|2.7
20+|~|~|~|Malignant|~|124605782|Female|Nerve sheath, benign and malignant|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116614175|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116614175|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117897259|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|24|117897259|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119151385|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119151385|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120303033|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|120303033|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121496050|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121496050|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|612963903|Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|107|612963903|Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122633364|Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|38|122633364|Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123755449|Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|22|123755449|Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124798153|Female|Neuroepithelial|2017|~|~|~
20+|~|~|~|Malignant|~|124798153|Female|Neuroepithelial|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124605782|Female|Neuroepithelial|2018|~|~|~
20+|~|~|~|Malignant|~|124605782|Female|Neuroepithelial|2018|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|186|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|204|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|222|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|248|116614175|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|116614175|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|243|117897259|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|117897259|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|214|119151385|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|119151385|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|182|120303033|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|~|~|~|Malignant|~|120303033|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|121496050|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121496050|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1163|612963903|Female|Neuronal/glial, neuronal|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|90|612963903|Female|Neuronal/glial, neuronal|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|229|122633364|Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122633364|Female|Neuronal/glial, neuronal|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|240|123755449|Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|123755449|Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|259|124798153|Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|124798153|Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|205|124605782|Female|Neuronal/glial, neuronal|2018|0.1|0.2|0.2
20+|~|~|~|Malignant|~|124605782|Female|Neuronal/glial, neuronal|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|355|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|362|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|382|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|374|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|365|114027722|Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|365|115293599|Female|Oligodendroglioma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116614175|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|330|116614175|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117897259|Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|322|117897259|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119151385|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|301|119151385|Female|Oligodendroglioma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120303033|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|348|120303033|Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121496050|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|306|121496050|Female|Oligodendroglioma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|612963903|Female|Oligodendroglioma|2014-2018|~|~|~
20+|0.3|0.3|0.3|Malignant|1566|612963903|Female|Oligodendroglioma|2014-2018|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|122633364|Female|Oligodendroglioma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|311|122633364|Female|Oligodendroglioma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|123755449|Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|335|123755449|Female|Oligodendroglioma|2016|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|124798153|Female|Oligodendroglioma|2017|~|~|~
20+|0.2|0.3|0.3|Malignant|318|124798153|Female|Oligodendroglioma|2017|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|124605782|Female|Oligodendroglioma|2018|~|~|~
20+|0.2|0.3|0.3|Malignant|303|124605782|Female|Oligodendroglioma|2018|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|68|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|88|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|51|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|116614175|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|116614175|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|117897259|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|117897259|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|108|119151385|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|119151385|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|120303033|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|120303033|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|121496050|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|34|121496050|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|456|612963903|Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|217|612963903|Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|122633364|Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|122633364|Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|79|123755449|Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|123755449|Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|124798153|Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|63|124798153|Female|Other mesenchymal|2017|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|87|124605782|Female|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|43|124605782|Female|Other mesenchymal|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|128|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|166|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116614175|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|167|116614175|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117897259|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|161|117897259|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119151385|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|123|119151385|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120303033|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|158|120303033|Female|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|121496050|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|147|121496050|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|612963903|Female|Pilocytic astrocytoma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|673|612963903|Female|Pilocytic astrocytoma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122633364|Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|147|122633364|Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123755449|Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|138|123755449|Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124798153|Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|126|124798153|Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124605782|Female|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|120|124605782|Female|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|45|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|42|116614175|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116614175|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|117897259|Female|Pineal parenchymal|2011|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|26|117897259|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|119151385|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119151385|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|120303033|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120303033|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|121496050|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121496050|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|197|612963903|Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|123|612963903|Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|51|122633364|Female|Pineal parenchymal|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|31|122633364|Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|123755449|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|123755449|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|37|124798153|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|124798153|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|124605782|Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|124605782|Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|3.7|4.0|3.8|Benign/Borderline|4174|109112165|Female|Pituitary|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.3|4.6|4.4|Benign/Borderline|4862|110320645|Female|Pituitary|2005|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.7|5.0|4.8|Benign/Borderline|5353|111567226|Female|Pituitary|2006|4.7|4.9|4.8
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5565|112783993|Female|Pituitary|2007|4.8|5.1|4.9
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|5.2|5.5|5.3|Benign/Borderline|6014|114027722|Female|Pituitary|2008|5.1|5.4|5.3
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.7|6.0|5.8|Benign/Borderline|6616|115293599|Female|Pituitary|2009|5.6|5.9|5.7
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Pituitary|2009|0.0|0.0|0.0
20+|5.6|5.9|5.8|Benign/Borderline|6633|116614175|Female|Pituitary|2010|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|16|116614175|Female|Pituitary|2010|0.0|0.0|0.0
20+|5.8|6.1|5.9|Benign/Borderline|6823|117897259|Female|Pituitary|2011|5.7|5.9|5.8
20+|~|~|~|Malignant|~|117897259|Female|Pituitary|2011|~|~|~
20+|6.1|6.4|6.3|Benign/Borderline|7306|119151385|Female|Pituitary|2012|6.0|6.3|6.1
20+|~|~|~|Malignant|~|119151385|Female|Pituitary|2012|~|~|~
20+|6.0|6.3|6.1|Benign/Borderline|7249|120303033|Female|Pituitary|2013|5.9|6.2|6.0
20+|~|~|~|Malignant|~|120303033|Female|Pituitary|2013|~|~|~
20+|6.1|6.4|6.2|Benign/Borderline|7381|121496050|Female|Pituitary|2014|5.9|6.2|6.1
20+|~|~|~|Malignant|~|121496050|Female|Pituitary|2014|~|~|~
20+|6.3|6.4|6.3|Benign/Borderline|38029|612963903|Female|Pituitary|2014-2018|6.1|6.3|6.2
20+|0.0|0.0|0.0|Malignant|45|612963903|Female|Pituitary|2014-2018|0.0|0.0|0.0
20+|6.3|6.6|6.4|Benign/Borderline|7712|122633364|Female|Pituitary|2015|6.1|6.4|6.3
20+|~|~|~|Malignant|~|122633364|Female|Pituitary|2015|~|~|~
20+|6.2|6.5|6.4|Benign/Borderline|7742|123755449|Female|Pituitary|2016|6.1|6.4|6.3
20+|~|~|~|Malignant|~|123755449|Female|Pituitary|2016|~|~|~
20+|6.4|6.7|6.5|Benign/Borderline|7980|124798153|Female|Pituitary|2017|6.3|6.5|6.4
20+|~|~|~|Malignant|~|124798153|Female|Pituitary|2017|~|~|~
20+|5.9|6.2|6.1|Benign/Borderline|7419|124605782|Female|Pituitary|2018|5.8|6.1|6.0
20+|~|~|~|Malignant|~|124605782|Female|Pituitary|2018|~|~|~
20+|19.8|20.3|20.0|Benign/Borderline|22794|109112165|Female|Total|2004|20.6|21.2|20.9
20+|7.5|7.8|7.6|Malignant|8751|109112165|Female|Total|2004|7.9|8.2|8.0
20+|22.3|22.9|22.6|Benign/Borderline|26158|110320645|Female|Total|2005|23.4|24.0|23.7
20+|7.5|7.8|7.7|Malignant|8924|110320645|Female|Total|2005|7.9|8.3|8.1
20+|23.5|24.0|23.7|Benign/Borderline|27850|111567226|Female|Total|2006|24.7|25.3|25.0
20+|7.5|7.8|7.6|Malignant|8989|111567226|Female|Total|2006|7.9|8.2|8.1
20+|24.2|24.7|24.4|Benign/Borderline|29102|112783993|Female|Total|2007|25.5|26.1|25.8
20+|7.4|7.8|7.6|Malignant|9087|112783993|Female|Total|2007|7.9|8.2|8.1
20+|25.5|26.0|25.7|Benign/Borderline|31129|114027722|Female|Total|2008|27.0|27.6|27.3
20+|7.4|7.7|7.6|Malignant|9233|114027722|Female|Total|2008|7.9|8.3|8.1
20+|27.2|27.8|27.5|Benign/Borderline|33716|115293599|Female|Total|2009|28.9|29.6|29.2
20+|7.4|7.7|7.6|Malignant|9385|115293599|Female|Total|2009|8.0|8.3|8.1
20+|26.4|27.0|26.7|Benign/Borderline|33209|116614175|Female|Total|2010|28.2|28.8|28.5
20+|7.2|7.5|7.4|Malignant|9326|116614175|Female|Total|2010|7.8|8.2|8.0
20+|26.9|27.5|27.2|Benign/Borderline|34180|117897259|Female|Total|2011|28.7|29.3|29.0
20+|7.0|7.3|7.2|Malignant|9209|117897259|Female|Total|2011|7.7|8.0|7.8
20+|27.7|28.2|28.0|Benign/Borderline|35705|119151385|Female|Total|2012|29.7|30.3|30.0
20+|7.1|7.4|7.3|Malignant|9482|119151385|Female|Total|2012|7.8|8.1|8.0
20+|27.7|28.2|27.9|Benign/Borderline|36185|120303033|Female|Total|2013|29.8|30.4|30.1
20+|7.1|7.4|7.3|Malignant|9655|120303033|Female|Total|2013|7.9|8.2|8.0
20+|28.1|28.7|28.4|Benign/Borderline|37352|121496050|Female|Total|2014|30.4|31.1|30.7
20+|6.9|7.2|7.0|Malignant|9513|121496050|Female|Total|2014|7.7|8.0|7.8
20+|28.4|28.7|28.6|Benign/Borderline|191673|612963903|Female|Total|2014-2018|31.1|31.4|31.3
20+|6.9|7.0|7.0|Malignant|48194|612963903|Female|Total|2014-2018|7.8|7.9|7.9
20+|28.7|29.3|29.0|Benign/Borderline|38707|122633364|Female|Total|2015|31.2|31.9|31.6
20+|7.1|7.4|7.3|Malignant|9914|122633364|Female|Total|2015|7.9|8.2|8.1
20+|28.7|29.3|29.0|Benign/Borderline|39145|123755449|Female|Total|2016|31.3|31.9|31.6
20+|6.9|7.2|7.0|Malignant|9819|123755449|Female|Total|2016|7.8|8.1|7.9
20+|28.6|29.2|28.9|Benign/Borderline|39752|124798153|Female|Total|2017|31.5|32.2|31.9
20+|6.8|7.1|6.9|Malignant|9832|124798153|Female|Total|2017|7.7|8.0|7.9
20+|27.1|27.6|27.3|Benign/Borderline|37814|124605782|Female|Total|2018|30.0|30.7|30.3
20+|6.5|6.7|6.6|Malignant|9441|124605782|Female|Total|2018|7.4|7.7|7.6
20+|2.2|2.4|2.3|Benign/Borderline|2572|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2847|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2974|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2979|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3103|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3262|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3070|116614175|Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116614175|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3323|117897259|Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117897259|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|3517|119151385|Female|Tumors of Cranial and Spinal Nerves|2012|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|26|119151385|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3690|120303033|Female|Tumors of Cranial and Spinal Nerves|2013|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|120303033|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3815|121496050|Female|Tumors of Cranial and Spinal Nerves|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|17|121496050|Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|18521|612963903|Female|Tumors of Cranial and Spinal Nerves|2014-2018|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|98|612963903|Female|Tumors of Cranial and Spinal Nerves|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3885|122633364|Female|Tumors of Cranial and Spinal Nerves|2015|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|23|122633364|Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3811|123755449|Female|Tumors of Cranial and Spinal Nerves|2016|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|26|123755449|Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3676|124798153|Female|Tumors of Cranial and Spinal Nerves|2017|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|18|124798153|Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3410|124605782|Female|Tumors of Cranial and Spinal Nerves|2018|2.6|2.8|2.7
20+|~|~|~|Malignant|~|124605782|Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|381|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.1|6.4|6.2|Malignant|7068|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|446|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7152|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|483|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7236|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|486|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7404|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.6
20+|0.4|0.5|0.4|Benign/Borderline|492|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7425|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|514|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7632|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.5|6.8|6.6
20+|0.4|0.5|0.5|Benign/Borderline|546|116614175|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7608|116614175|Female|Tumors of Neuroepthelial Tissue|2010|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|565|117897259|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|6.0|Malignant|7561|117897259|Female|Tumors of Neuroepthelial Tissue|2011|6.3|6.6|6.4
20+|0.4|0.5|0.5|Benign/Borderline|545|119151385|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7805|119151385|Female|Tumors of Neuroepthelial Tissue|2012|6.4|6.7|6.6
20+|0.4|0.5|0.4|Benign/Borderline|526|120303033|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.9|6.2|6.0|Malignant|7916|120303033|Female|Tumors of Neuroepthelial Tissue|2013|6.4|6.7|6.6
20+|0.5|0.5|0.5|Benign/Borderline|597|121496050|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.5|0.5
20+|5.6|5.8|5.7|Malignant|7633|121496050|Female|Tumors of Neuroepthelial Tissue|2014|6.1|6.4|6.3
20+|0.5|0.5|0.5|Benign/Borderline|2920|612963903|Female|Tumors of Neuroepthelial Tissue|2014-2018|0.5|0.5|0.5
20+|5.7|5.8|5.8|Malignant|39353|612963903|Female|Tumors of Neuroepthelial Tissue|2014-2018|6.4|6.5|6.4
20+|0.5|0.6|0.5|Benign/Borderline|612|122633364|Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.5|0.5
20+|5.9|6.1|6.0|Malignant|8112|122633364|Female|Tumors of Neuroepthelial Tissue|2015|6.5|6.8|6.6
20+|0.5|0.5|0.5|Benign/Borderline|586|123755449|Female|Tumors of Neuroepthelial Tissue|2016|0.4|0.5|0.5
20+|5.7|6.0|5.9|Malignant|8097|123755449|Female|Tumors of Neuroepthelial Tissue|2016|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|598|124798153|Female|Tumors of Neuroepthelial Tissue|2017|0.4|0.5|0.5
20+|5.6|5.9|5.7|Malignant|8038|124798153|Female|Tumors of Neuroepthelial Tissue|2017|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|544|124605782|Female|Tumors of Neuroepthelial Tissue|2018|0.4|0.5|0.4
20+|5.3|5.6|5.5|Malignant|7740|124605782|Female|Tumors of Neuroepthelial Tissue|2018|6.1|6.4|6.2
20+|3.9|4.2|4.0|Benign/Borderline|4379|109112165|Female|Tumors of Sellar Region|2004|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|5047|110320645|Female|Tumors of Sellar Region|2005|4.4|4.7|4.6
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.9|5.2|5.0|Benign/Borderline|5555|111567226|Female|Tumors of Sellar Region|2006|4.8|5.1|5.0
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|5.0|5.3|5.2|Benign/Borderline|5785|112783993|Female|Tumors of Sellar Region|2007|5.0|5.3|5.1
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|6239|114027722|Female|Tumors of Sellar Region|2008|5.3|5.6|5.5
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.9|6.2|6.0|Benign/Borderline|6846|115293599|Female|Tumors of Sellar Region|2009|5.8|6.1|5.9
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.8|6.1|6.0|Benign/Borderline|6872|116614175|Female|Tumors of Sellar Region|2010|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|16|116614175|Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|6.0|6.2|6.1|Benign/Borderline|7045|117897259|Female|Tumors of Sellar Region|2011|5.8|6.1|6.0
20+|~|~|~|Malignant|~|117897259|Female|Tumors of Sellar Region|2011|~|~|~
20+|6.3|6.6|6.5|Benign/Borderline|7532|119151385|Female|Tumors of Sellar Region|2012|6.2|6.5|6.3
20+|~|~|~|Malignant|~|119151385|Female|Tumors of Sellar Region|2012|~|~|~
20+|6.2|6.5|6.3|Benign/Borderline|7493|120303033|Female|Tumors of Sellar Region|2013|6.1|6.4|6.2
20+|0.0|0.0|0.0|Malignant|16|120303033|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|6.3|6.6|6.4|Benign/Borderline|7604|121496050|Female|Tumors of Sellar Region|2014|6.1|6.4|6.3
20+|~|~|~|Malignant|~|121496050|Female|Tumors of Sellar Region|2014|~|~|~
20+|6.5|6.6|6.5|Benign/Borderline|39181|612963903|Female|Tumors of Sellar Region|2014-2018|6.3|6.5|6.4
20+|0.0|0.0|0.0|Malignant|48|612963903|Female|Tumors of Sellar Region|2014-2018|0.0|0.0|0.0
20+|6.5|6.8|6.6|Benign/Borderline|7950|122633364|Female|Tumors of Sellar Region|2015|6.3|6.6|6.5
20+|~|~|~|Malignant|~|122633364|Female|Tumors of Sellar Region|2015|~|~|~
20+|6.4|6.7|6.6|Benign/Borderline|7964|123755449|Female|Tumors of Sellar Region|2016|6.3|6.6|6.4
20+|~|~|~|Malignant|~|123755449|Female|Tumors of Sellar Region|2016|~|~|~
20+|6.6|6.9|6.7|Benign/Borderline|8224|124798153|Female|Tumors of Sellar Region|2017|6.4|6.7|6.6
20+|~|~|~|Malignant|~|124798153|Female|Tumors of Sellar Region|2017|~|~|~
20+|6.1|6.4|6.2|Benign/Borderline|7650|124605782|Female|Tumors of Sellar Region|2018|6.0|6.3|6.1
20+|~|~|~|Malignant|~|124605782|Female|Tumors of Sellar Region|2018|~|~|~
20+|12.3|12.7|12.5|Benign/Borderline|14511|109112165|Female|Tumors of the Meninges|2004|13.1|13.5|13.3
20+|0.2|0.3|0.3|Malignant|300|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.9|14.3|14.1|Benign/Borderline|16618|110320645|Female|Tumors of the Meninges|2005|14.8|15.3|15.1
20+|0.2|0.3|0.3|Malignant|307|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.5|14.9|14.7|Benign/Borderline|17669|111567226|Female|Tumors of the Meninges|2006|15.6|16.1|15.8
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|15.0|15.5|15.3|Benign/Borderline|18603|112783993|Female|Tumors of the Meninges|2007|16.3|16.7|16.5
20+|0.2|0.3|0.3|Malignant|310|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.8|16.3|16.1|Benign/Borderline|19946|114027722|Female|Tumors of the Meninges|2008|17.3|17.7|17.5
20+|0.2|0.2|0.2|Malignant|270|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|16.9|17.3|17.1|Benign/Borderline|21597|115293599|Female|Tumors of the Meninges|2009|18.5|19.0|18.7
20+|0.2|0.2|0.2|Malignant|230|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|21197|116614175|Female|Tumors of the Meninges|2010|17.9|18.4|18.2
20+|0.2|0.2|0.2|Malignant|243|116614175|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|16.4|16.9|16.6|Benign/Borderline|21639|117897259|Female|Tumors of the Meninges|2011|18.1|18.6|18.4
20+|0.1|0.2|0.2|Malignant|217|117897259|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|16.7|17.2|17.0|Benign/Borderline|22475|119151385|Female|Tumors of the Meninges|2012|18.6|19.1|18.9
20+|0.2|0.2|0.2|Malignant|241|119151385|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|16.9|17.3|17.1|Benign/Borderline|22920|120303033|Female|Tumors of the Meninges|2013|18.8|19.3|19.1
20+|0.2|0.2|0.2|Malignant|271|120303033|Female|Tumors of the Meninges|2013|0.2|0.3|0.2
20+|17.1|17.6|17.4|Benign/Borderline|23760|121496050|Female|Tumors of the Meninges|2014|19.3|19.8|19.6
20+|0.2|0.2|0.2|Malignant|255|121496050|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|17.6|17.8|17.7|Benign/Borderline|124247|612963903|Female|Tumors of the Meninges|2014-2018|20.2|20.4|20.3
20+|0.2|0.2|0.2|Malignant|1158|612963903|Female|Tumors of the Meninges|2014-2018|0.2|0.2|0.2
20+|17.6|18.0|17.8|Benign/Borderline|24797|122633364|Female|Tumors of the Meninges|2015|20.0|20.5|20.2
20+|0.2|0.2|0.2|Malignant|243|122633364|Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|17.8|18.3|18.0|Benign/Borderline|25426|123755449|Female|Tumors of the Meninges|2016|20.3|20.8|20.5
20+|0.1|0.2|0.2|Malignant|213|123755449|Female|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|17.8|18.3|18.1|Benign/Borderline|25978|124798153|Female|Tumors of the Meninges|2017|20.6|21.1|20.8
20+|0.1|0.2|0.2|Malignant|241|124798153|Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|17.1|17.5|17.3|Benign/Borderline|25053|124605782|Female|Tumors of the Meninges|2018|19.9|20.4|20.1
20+|0.1|0.2|0.2|Malignant|214|124605782|Female|Tumors of the Meninges|2018|0.1|0.2|0.2
20+|0.8|0.9|0.8|Benign/Borderline|933|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.9
20+|0.5|0.6|0.6|Malignant|709|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1162|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|723|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1133|111567226|Female|Unclassified Tumors|2006|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|726|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.1|1.0|Benign/Borderline|1212|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|655|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1315|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.2
20+|0.5|0.6|0.6|Malignant|767|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1452|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.3
20+|0.5|0.6|0.6|Malignant|790|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1491|116614175|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|655|116614175|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1570|117897259|Female|Unclassified Tumors|2011|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|651|117897259|Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1600|119151385|Female|Unclassified Tumors|2012|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|658|119151385|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1530|120303033|Female|Unclassified Tumors|2013|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|669|120303033|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1545|121496050|Female|Unclassified Tumors|2014|1.2|1.3|1.3
20+|0.5|0.5|0.5|Malignant|745|121496050|Female|Unclassified Tumors|2014|0.6|0.7|0.6
20+|1.0|1.0|1.0|Benign/Borderline|6667|612963903|Female|Unclassified Tumors|2014-2018|1.1|1.1|1.1
20+|0.4|0.5|0.4|Malignant|3396|612963903|Female|Unclassified Tumors|2014-2018|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1430|122633364|Female|Unclassified Tumors|2015|1.1|1.2|1.2
20+|0.5|0.5|0.5|Malignant|737|122633364|Female|Unclassified Tumors|2015|0.6|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1327|123755449|Female|Unclassified Tumors|2016|1.0|1.1|1.1
20+|0.4|0.4|0.4|Malignant|616|123755449|Female|Unclassified Tumors|2016|0.5|0.5|0.5
20+|0.9|1.0|0.9|Benign/Borderline|1252|124798153|Female|Unclassified Tumors|2017|0.9|1.1|1.0
20+|0.4|0.5|0.4|Malignant|681|124798153|Female|Unclassified Tumors|2017|0.5|0.6|0.5
20+|0.8|0.9|0.8|Benign/Borderline|1138|124605782|Female|Unclassified Tumors|2018|0.9|1.0|0.9
20+|0.4|0.5|0.4|Malignant|644|124605782|Female|Unclassified Tumors|2018|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|50|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|63|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|60|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|76|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|116614175|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116614175|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|80|117897259|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|117897259|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|119151385|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119151385|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|120303033|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120303033|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|121496050|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|121496050|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|510|612963903|Female|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|156|612963903|Female|Unique astrocytoma variants|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|122633364|Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|122633364|Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|110|123755449|Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|123755449|Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|124798153|Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|124798153|Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|124605782|Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|124605782|Female|Unique astrocytoma variants|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109525743|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109525743|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110832735|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|110832735|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112197441|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|21|112197441|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|19|113445798|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|113445798|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114699102|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114699102|Male|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|160|579444338|Male|All other|2014-2018|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|317|579444338|Male|All other|2014-2018|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|115921555|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115921555|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|44|117079280|Male|All other|2016|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|27|117079280|Male|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|40|118124677|Male|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|118124677|Male|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|38|117924727|Male|All other|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|214|117924727|Male|All other|2018|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|671|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|701|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|699|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|674|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|710|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|715|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109525743|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|711|109525743|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|110832735|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|710|110832735|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112197441|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|752|112197441|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113445798|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|796|113445798|Male|Anaplastic astrocytoma|2013|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|114699102|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|792|114699102|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|579444338|Male|Anaplastic astrocytoma|2014-2018|~|~|~
20+|0.6|0.7|0.7|Malignant|3940|579444338|Male|Anaplastic astrocytoma|2014-2018|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|115921555|Male|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|780|115921555|Male|Anaplastic astrocytoma|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117079280|Male|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|830|117079280|Male|Anaplastic astrocytoma|2016|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118124677|Male|Anaplastic astrocytoma|2017|~|~|~
20+|0.6|0.7|0.7|Malignant|781|118124677|Male|Anaplastic astrocytoma|2017|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117924727|Male|Anaplastic astrocytoma|2018|~|~|~
20+|0.6|0.7|0.6|Malignant|779|117924727|Male|Anaplastic astrocytoma|2018|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|210|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|210|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|217|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|184|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|190|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|190|108197539|Male|Anaplastic oligodendroglioma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109525743|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|195|109525743|Male|Anaplastic oligodendroglioma|2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110832735|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|184|110832735|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112197441|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|188|112197441|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113445798|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|221|113445798|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114699102|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|205|114699102|Male|Anaplastic oligodendroglioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|579444338|Male|Anaplastic oligodendroglioma|2014-2018|~|~|~
20+|0.2|0.2|0.2|Malignant|1003|579444338|Male|Anaplastic oligodendroglioma|2014-2018|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|115921555|Male|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|190|115921555|Male|Anaplastic oligodendroglioma|2015|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117079280|Male|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.2|0.2|0.2|Malignant|201|117079280|Male|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|118124677|Male|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|238|118124677|Male|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117924727|Male|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.2|0.1|Malignant|176|117924727|Male|Anaplastic oligodendroglioma|2018|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|638|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|633|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|649|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|628|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|629|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|574|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109525743|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|621|109525743|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110832735|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|585|110832735|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|112197441|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.5|0.5|0.5|Malignant|561|112197441|Male|Astrocytoma, NOS|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113445798|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|568|113445798|Male|Astrocytoma, NOS|2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114699102|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.6|0.5|Malignant|602|114699102|Male|Astrocytoma, NOS|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|579444338|Male|Astrocytoma, NOS|2014-2018|~|~|~
20+|0.6|0.6|0.6|Malignant|3330|579444338|Male|Astrocytoma, NOS|2014-2018|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|115921555|Male|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|684|115921555|Male|Astrocytoma, NOS|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117079280|Male|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|693|117079280|Male|Astrocytoma, NOS|2016|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|118124677|Male|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|695|118124677|Male|Astrocytoma, NOS|2017|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117924727|Male|Astrocytoma, NOS|2018|~|~|~
20+|0.5|0.6|0.6|Malignant|676|117924727|Male|Astrocytoma, NOS|2018|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|25|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109525743|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109525743|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|110832735|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110832735|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|112197441|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112197441|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|113445798|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113445798|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|114699102|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114699102|Male|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|182|579444338|Male|Choroid plexus|2014-2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|579444338|Male|Choroid plexus|2014-2018|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|115921555|Male|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115921555|Male|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|117079280|Male|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117079280|Male|Choroid plexus|2016|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|118124677|Male|Choroid plexus|2017|0.0|0.1|0.0
20+|~|~|~|Malignant|~|118124677|Male|Choroid plexus|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|117924727|Male|Choroid plexus|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117924727|Male|Choroid plexus|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|187|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|232|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|190|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|201|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|109525743|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109525743|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|196|110832735|Male|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110832735|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112197441|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112197441|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|229|113445798|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113445798|Male|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|207|114699102|Male|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114699102|Male|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1129|579444338|Male|Craniopharyngioma|2014-2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|579444338|Male|Craniopharyngioma|2014-2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|115921555|Male|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115921555|Male|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|245|117079280|Male|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117079280|Male|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|240|118124677|Male|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118124677|Male|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|117924727|Male|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117924727|Male|Craniopharyngioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|145|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|210|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109525743|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109525743|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110832735|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|137|110832735|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112197441|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|113|112197441|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113445798|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|103|113445798|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114699102|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|69|114699102|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|579444338|Male|Diffuse astrocytoma|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|168|579444338|Male|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115921555|Male|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.1|0.0|Malignant|49|115921555|Male|Diffuse astrocytoma|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|117079280|Male|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|23|117079280|Male|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118124677|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|118124677|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|117924727|Male|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Malignant|~|117924727|Male|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|97|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|105|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|133|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109525743|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109525743|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110832735|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|110832735|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112197441|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|93|112197441|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113445798|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|97|113445798|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114699102|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|107|114699102|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|579444338|Male|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|502|579444338|Male|Embryonal/primitive/medulloblastoma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115921555|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|100|115921555|Male|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117079280|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|119|117079280|Male|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118124677|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|98|118124677|Male|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117924727|Male|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|84|117924727|Male|Embryonal/primitive/medulloblastoma|2018|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|150|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|161|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|147|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|109525743|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109525743|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|110832735|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|110832735|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|163|112197441|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112197441|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|158|113445798|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113445798|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|168|114699102|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114699102|Male|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|788|579444338|Male|Ependymoma variants|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|16|579444338|Male|Ependymoma variants|2014-2018|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|160|115921555|Male|Ependymoma variants|2015|0.1|0.2|0.1
20+|~|~|~|Malignant|~|115921555|Male|Ependymoma variants|2015|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|171|117079280|Male|Ependymoma variants|2016|0.1|0.2|0.1
20+|~|~|~|Malignant|~|117079280|Male|Ependymoma variants|2016|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|160|118124677|Male|Ependymoma variants|2017|0.1|0.2|0.1
20+|~|~|~|Malignant|~|118124677|Male|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|133|117924727|Male|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117924727|Male|Ependymoma variants|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|303|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|301|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|292|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|290|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|320|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|340|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109525743|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|333|109525743|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110832735|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|299|110832735|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112197441|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|329|112197441|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113445798|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|301|113445798|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|22|114699102|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|323|114699102|Male|Ependymoma/anaplastic ependymoma|2014|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|71|579444338|Male|Ependymoma/anaplastic ependymoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1542|579444338|Male|Ependymoma/anaplastic ependymoma|2014-2018|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115921555|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|308|115921555|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117079280|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.3|Malignant|328|117079280|Male|Ependymoma/anaplastic ependymoma|2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118124677|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|300|118124677|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117924727|Male|Ependymoma/anaplastic ependymoma|2018|~|~|~
20+|0.2|0.3|0.2|Malignant|292|117924727|Male|Ependymoma/anaplastic ependymoma|2018|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|41|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|47|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|34|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|109525743|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109525743|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|110832735|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|60|110832735|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|32|112197441|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|112197441|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|113445798|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|46|113445798|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|114699102|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|62|114699102|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|136|579444338|Male|Germ Cell Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|300|579444338|Male|Germ Cell Tumors|2014-2018|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|115921555|Male|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|55|115921555|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|117079280|Male|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|67|117079280|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|118124677|Male|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|60|118124677|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|20|117924727|Male|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|58|117924727|Male|Germ Cell Tumors|2018|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5465|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5545|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5510|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.5|5.7|5.6|Malignant|5821|105697783|Male|Glioblastoma|2007|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.7|Malignant|6012|106947980|Male|Glioblastoma|2008|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6015|108197539|Male|Glioblastoma|2009|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109525743|Male|Glioblastoma|2010|~|~|~
20+|5.4|5.6|5.5|Malignant|6122|109525743|Male|Glioblastoma|2010|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|110832735|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6305|110832735|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|112197441|Male|Glioblastoma|2012|~|~|~
20+|5.5|5.7|5.6|Malignant|6526|112197441|Male|Glioblastoma|2012|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|113445798|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.6|Malignant|6642|113445798|Male|Glioblastoma|2013|5.7|6.0|5.9
20+|~|~|~|Benign/Borderline|~|114699102|Male|Glioblastoma|2014|~|~|~
20+|5.5|5.7|5.6|Malignant|6805|114699102|Male|Glioblastoma|2014|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|579444338|Male|Glioblastoma|2014-2018|~|~|~
20+|5.5|5.7|5.6|Malignant|35210|579444338|Male|Glioblastoma|2014-2018|6.0|6.1|6.1
20+|~|~|~|Benign/Borderline|~|115921555|Male|Glioblastoma|2015|~|~|~
20+|5.4|5.7|5.6|Malignant|6901|115921555|Male|Glioblastoma|2015|5.8|6.1|6.0
20+|~|~|~|Benign/Borderline|~|117079280|Male|Glioblastoma|2016|~|~|~
20+|5.5|5.8|5.7|Malignant|7211|117079280|Male|Glioblastoma|2016|6.0|6.3|6.2
20+|~|~|~|Benign/Borderline|~|118124677|Male|Glioblastoma|2017|~|~|~
20+|5.5|5.8|5.6|Malignant|7327|118124677|Male|Glioblastoma|2017|6.1|6.3|6.2
20+|~|~|~|Benign/Borderline|~|117924727|Male|Glioblastoma|2018|~|~|~
20+|5.4|5.6|5.5|Malignant|7230|117924727|Male|Glioblastoma|2018|6.0|6.3|6.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|422|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|443|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|445|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|464|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.5|Malignant|481|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|456|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109525743|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|409|109525743|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|110832735|Male|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|494|110832735|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112197441|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|488|112197441|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113445798|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|461|113445798|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114699102|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|495|114699102|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|99|579444338|Male|Glioma malignant, NOS|2014-2018|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|2627|579444338|Male|Glioma malignant, NOS|2014-2018|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|22|115921555|Male|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|483|115921555|Male|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|117079280|Male|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|538|117079280|Male|Glioma malignant, NOS|2016|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|17|118124677|Male|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.5|0.5|0.5|Malignant|584|118124677|Male|Glioma malignant, NOS|2017|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117924727|Male|Glioma malignant, NOS|2018|~|~|~
20+|0.4|0.5|0.5|Malignant|552|117924727|Male|Glioma malignant, NOS|2018|0.4|0.5|0.5
20+|0.2|0.3|0.2|Benign/Borderline|250|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|287|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|276|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|258|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|290|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|275|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.3
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|304|109525743|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109525743|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|277|110832735|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110832735|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|285|112197441|Male|Hemangioblastoma|2012|0.2|0.3|0.3
20+|~|~|~|Malignant|~|112197441|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|274|113445798|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113445798|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|277|114699102|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114699102|Male|Hemangioblastoma|2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1451|579444338|Male|Hemangioblastoma|2014-2018|0.2|0.3|0.3
20+|0.0|0.0|0.0|Malignant|17|579444338|Male|Hemangioblastoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|292|115921555|Male|Hemangioblastoma|2015|0.2|0.3|0.3
20+|~|~|~|Malignant|~|115921555|Male|Hemangioblastoma|2015|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|279|117079280|Male|Hemangioblastoma|2016|0.2|0.3|0.2
20+|~|~|~|Malignant|~|117079280|Male|Hemangioblastoma|2016|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|330|118124677|Male|Hemangioblastoma|2017|0.3|0.3|0.3
20+|~|~|~|Malignant|~|118124677|Male|Hemangioblastoma|2017|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|291|117924727|Male|Hemangioblastoma|2018|0.2|0.3|0.2
20+|~|~|~|Malignant|~|117924727|Male|Hemangioblastoma|2018|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|140|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|234|104488268|Male|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|269|105697783|Male|Hemangioma|2007|0.2|0.3|0.3
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|327|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|434|108197539|Male|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|449|109525743|Male|Hemangioma|2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|109525743|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|507|110832735|Male|Hemangioma|2011|0.4|0.5|0.5
20+|~|~|~|Malignant|~|110832735|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|513|112197441|Male|Hemangioma|2012|0.4|0.5|0.5
20+|~|~|~|Malignant|~|112197441|Male|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|508|113445798|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|113445798|Male|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|500|114699102|Male|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114699102|Male|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2180|579444338|Male|Hemangioma|2014-2018|0.4|0.4|0.4
20+|~|~|~|Malignant|~|579444338|Male|Hemangioma|2014-2018|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|452|115921555|Male|Hemangioma|2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|115921555|Male|Hemangioma|2015|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|411|117079280|Male|Hemangioma|2016|0.3|0.4|0.4
20+|~|~|~|Malignant|~|117079280|Male|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|420|118124677|Male|Hemangioma|2017|0.3|0.4|0.4
20+|~|~|~|Malignant|~|118124677|Male|Hemangioma|2017|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|401|117924727|Male|Hemangioma|2018|0.3|0.4|0.3
20+|~|~|~|Malignant|~|117924727|Male|Hemangioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|35|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109525743|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109525743|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110832735|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110832735|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112197441|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112197441|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113445798|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|29|113445798|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114699102|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114699102|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|579444338|Male|Local Extensions from Regional Tumors|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|114|579444338|Male|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115921555|Male|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|23|115921555|Male|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117079280|Male|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|26|117079280|Male|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118124677|Male|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|22|118124677|Male|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117924727|Male|Local Extensions from Regional Tumors|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|18|117924727|Male|Local Extensions from Regional Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|777|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|762|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|737|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|774|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|763|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109525743|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|756|109525743|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110832735|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|808|110832735|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|112197441|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|757|112197441|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113445798|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|730|113445798|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|114699102|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|820|114699102|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|579444338|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
20+|0.7|0.7|0.7|Malignant|4149|579444338|Male|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|115921555|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|821|115921555|Male|Lymphomas and Hematopoietic Neoplasms|2015|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|117079280|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|822|117079280|Male|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118124677|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.7|0.8|0.7|Malignant|885|118124677|Male|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|117924727|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.6|0.7|0.6|Malignant|829|117924727|Male|Lymphomas and Hematopoietic Neoplasms|2018|0.7|0.8|0.7
20+|5.1|5.4|5.2|Benign/Borderline|4914|101938779|Male|Meningioma|2004|4.7|5.0|4.8
20+|0.2|0.2|0.2|Malignant|171|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.6|5.9|5.8|Benign/Borderline|5483|103190694|Male|Meningioma|2005|5.2|5.5|5.3
20+|0.1|0.2|0.2|Malignant|155|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.9|6.2|6.1|Benign/Borderline|5900|104488268|Male|Meningioma|2006|5.5|5.8|5.6
20+|0.1|0.2|0.2|Malignant|154|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|6.0|6.3|6.2|Benign/Borderline|6120|105697783|Male|Meningioma|2007|5.6|5.9|5.8
20+|0.1|0.2|0.2|Malignant|174|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.5|6.8|6.6|Benign/Borderline|6730|106947980|Male|Meningioma|2008|6.1|6.4|6.3
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.9|7.3|7.1|Benign/Borderline|7281|108197539|Male|Meningioma|2009|6.6|6.9|6.7
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.8|7.1|7.0|Benign/Borderline|7309|109525743|Male|Meningioma|2010|6.5|6.8|6.7
20+|0.1|0.1|0.1|Malignant|122|109525743|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.8|7.1|7.0|Benign/Borderline|7510|110832735|Male|Meningioma|2011|6.6|6.9|6.8
20+|0.1|0.2|0.1|Malignant|143|110832735|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.8|7.2|7.0|Benign/Borderline|7722|112197441|Male|Meningioma|2012|6.7|7.0|6.9
20+|0.1|0.2|0.1|Malignant|153|112197441|Male|Meningioma|2012|0.1|0.2|0.1
20+|7.1|7.5|7.3|Benign/Borderline|8212|113445798|Male|Meningioma|2013|7.1|7.4|7.2
20+|0.1|0.2|0.1|Malignant|157|113445798|Male|Meningioma|2013|0.1|0.2|0.1
20+|7.1|7.4|7.3|Benign/Borderline|8354|114699102|Male|Meningioma|2014|7.1|7.4|7.3
20+|0.1|0.2|0.1|Malignant|166|114699102|Male|Meningioma|2014|0.1|0.2|0.1
20+|7.4|7.6|7.5|Benign/Borderline|44662|579444338|Male|Meningioma|2014-2018|7.6|7.8|7.7
20+|0.1|0.1|0.1|Malignant|747|579444338|Male|Meningioma|2014-2018|0.1|0.1|0.1
20+|7.4|7.7|7.5|Benign/Borderline|8871|115921555|Male|Meningioma|2015|7.5|7.8|7.7
20+|0.1|0.1|0.1|Malignant|150|115921555|Male|Meningioma|2015|0.1|0.2|0.1
20+|7.4|7.7|7.6|Benign/Borderline|9085|117079280|Male|Meningioma|2016|7.6|7.9|7.8
20+|0.1|0.1|0.1|Malignant|158|117079280|Male|Meningioma|2016|0.1|0.2|0.1
20+|7.6|7.9|7.7|Benign/Borderline|9507|118124677|Male|Meningioma|2017|7.9|8.2|8.0
20+|0.1|0.1|0.1|Malignant|149|118124677|Male|Meningioma|2017|0.1|0.1|0.1
20+|7.2|7.5|7.3|Benign/Borderline|9109|117924727|Male|Meningioma|2018|7.6|7.9|7.7
20+|0.1|0.1|0.1|Malignant|128|117924727|Male|Meningioma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|296|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|330|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|366|104488268|Male|Mixed glioma|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|348|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|338|106947980|Male|Mixed glioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|393|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109525743|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|342|109525743|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110832735|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|364|110832735|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112197441|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|331|112197441|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113445798|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|371|113445798|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114699102|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|268|114699102|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|579444338|Male|Mixed glioma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|510|579444338|Male|Mixed glioma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115921555|Male|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|144|115921555|Male|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117079280|Male|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|65|117079280|Male|Mixed glioma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118124677|Male|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|28|118124677|Male|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117924727|Male|Mixed glioma|2018|~|~|~
20+|~|~|~|Malignant|~|117924727|Male|Mixed glioma|2018|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|508|101938779|Male|Neoplasm, unspecified|2004|0.5|0.5|0.5
20+|0.6|0.7|0.7|Malignant|609|101938779|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|628|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|604|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|618|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|566|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|589|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|566|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|612|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|616|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|615|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|640|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|667|109525743|Male|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.6|0.7|0.6|Malignant|601|109525743|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|631|110832735|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|610|110832735|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|714|112197441|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|619|112197441|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|687|113445798|Male|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|610|113445798|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|637|114699102|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|663|114699102|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|2905|579444338|Male|Neoplasm, unspecified|2014-2018|0.5|0.5|0.5
20+|0.5|0.6|0.5|Malignant|3068|579444338|Male|Neoplasm, unspecified|2014-2018|0.5|0.5|0.5
20+|0.5|0.6|0.5|Benign/Borderline|632|115921555|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|628|115921555|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|585|117079280|Male|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.5|0.6|0.5|Malignant|630|117079280|Male|Neoplasm, unspecified|2016|0.5|0.6|0.5
20+|0.4|0.5|0.5|Benign/Borderline|553|118124677|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|0.4|0.5|0.5|Malignant|560|118124677|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|0.4|0.5|0.4|Benign/Borderline|507|117924727|Male|Neoplasm, unspecified|2018|0.4|0.5|0.4
20+|0.5|0.6|0.5|Malignant|618|117924727|Male|Neoplasm, unspecified|2018|0.5|0.6|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2330|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2684|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2665|104488268|Male|Nerve sheath, benign and malignant|2006|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2751|105697783|Male|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2723|106947980|Male|Nerve sheath, benign and malignant|2008|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2910|108197539|Male|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2929|109525743|Male|Nerve sheath, benign and malignant|2010|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|109525743|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3030|110832735|Male|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|17|110832735|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3206|112197441|Male|Nerve sheath, benign and malignant|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|24|112197441|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3286|113445798|Male|Nerve sheath, benign and malignant|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113445798|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3554|114699102|Male|Nerve sheath, benign and malignant|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|114699102|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|17024|579444338|Male|Nerve sheath, benign and malignant|2014-2018|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|99|579444338|Male|Nerve sheath, benign and malignant|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3530|115921555|Male|Nerve sheath, benign and malignant|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|16|115921555|Male|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3433|117079280|Male|Nerve sheath, benign and malignant|2016|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|22|117079280|Male|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3416|118124677|Male|Nerve sheath, benign and malignant|2017|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|25|118124677|Male|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3187|117924727|Male|Nerve sheath, benign and malignant|2018|2.6|2.8|2.7
20+|~|~|~|Malignant|~|117924727|Male|Nerve sheath, benign and malignant|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109525743|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109525743|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110832735|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|29|110832735|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112197441|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112197441|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113445798|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113445798|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114699102|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|35|114699102|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|579444338|Male|Neuroepithelial|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|123|579444338|Male|Neuroepithelial|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115921555|Male|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|32|115921555|Male|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117079280|Male|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|25|117079280|Male|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118124677|Male|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|19|118124677|Male|Neuroepithelial|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117924727|Male|Neuroepithelial|2018|~|~|~
20+|~|~|~|Malignant|~|117924727|Male|Neuroepithelial|2018|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|161|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|191|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|201|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|185|105697783|Male|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|234|109525743|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109525743|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|187|110832735|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|110832735|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|112197441|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112197441|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|113445798|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|113445798|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|224|114699102|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|114699102|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1204|579444338|Male|Neuronal/glial, neuronal|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|77|579444338|Male|Neuronal/glial, neuronal|2014-2018|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|267|115921555|Male|Neuronal/glial, neuronal|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Malignant|16|115921555|Male|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|240|117079280|Male|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|117079280|Male|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|242|118124677|Male|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118124677|Male|Neuronal/glial, neuronal|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|117924727|Male|Neuronal/glial, neuronal|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117924727|Male|Neuronal/glial, neuronal|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|478|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|440|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|468|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|439|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|411|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|475|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109525743|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|470|109525743|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|110832735|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|442|110832735|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112197441|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|370|112197441|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113445798|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|369|113445798|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114699102|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|414|114699102|Male|Oligodendroglioma|2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|579444338|Male|Oligodendroglioma|2014-2018|~|~|~
20+|0.3|0.4|0.4|Malignant|1961|579444338|Male|Oligodendroglioma|2014-2018|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|115921555|Male|Oligodendroglioma|2015|~|~|~
20+|0.3|0.4|0.4|Malignant|403|115921555|Male|Oligodendroglioma|2015|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|117079280|Male|Oligodendroglioma|2016|~|~|~
20+|0.3|0.4|0.4|Malignant|404|117079280|Male|Oligodendroglioma|2016|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|118124677|Male|Oligodendroglioma|2017|~|~|~
20+|0.3|0.4|0.4|Malignant|401|118124677|Male|Oligodendroglioma|2017|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|117924727|Male|Oligodendroglioma|2018|~|~|~
20+|0.3|0.4|0.3|Malignant|354|117924727|Male|Oligodendroglioma|2018|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|83|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|73|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|36|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|40|105697783|Male|Other mesenchymal|2007|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|50|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|78|109525743|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|109525743|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|68|110832735|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|45|110832735|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|112197441|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|112197441|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|113445798|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|113445798|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|114699102|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|114699102|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|430|579444338|Male|Other mesenchymal|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|237|579444338|Male|Other mesenchymal|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|108|115921555|Male|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|115921555|Male|Other mesenchymal|2015|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|117079280|Male|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|117079280|Male|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|80|118124677|Male|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|118124677|Male|Other mesenchymal|2017|0.0|0.1|0.0
20+|0.0|0.1|0.1|Benign/Borderline|76|117924727|Male|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|59|117924727|Male|Other mesenchymal|2018|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|151|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|157|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|138|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109525743|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|163|109525743|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|110832735|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|175|110832735|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112197441|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|147|112197441|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113445798|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|145|113445798|Male|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114699102|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|152|114699102|Male|Pilocytic astrocytoma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|579444338|Male|Pilocytic astrocytoma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|740|579444338|Male|Pilocytic astrocytoma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115921555|Male|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|149|115921555|Male|Pilocytic astrocytoma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117079280|Male|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|160|117079280|Male|Pilocytic astrocytoma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|118124677|Male|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|140|118124677|Male|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117924727|Male|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|142|117924727|Male|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109525743|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109525743|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|110832735|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|110832735|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|112197441|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112197441|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113445798|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113445798|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|114699102|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|114699102|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|91|579444338|Male|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|125|579444338|Male|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115921555|Male|Pineal parenchymal|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|28|115921555|Male|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|117079280|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|117079280|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118124677|Male|Pineal parenchymal|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|27|118124677|Male|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|117924727|Male|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|117924727|Male|Pineal parenchymal|2018|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|3458|101938779|Male|Pituitary|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|3806|103190694|Male|Pituitary|2005|3.6|3.8|3.7
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.9|4.1|4.0|Benign/Borderline|4084|104488268|Male|Pituitary|2006|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4493|105697783|Male|Pituitary|2007|4.1|4.4|4.3
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|4890|106947980|Male|Pituitary|2008|4.4|4.7|4.6
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.7|5.0|4.8|Benign/Borderline|5229|108197539|Male|Pituitary|2009|4.7|5.0|4.8
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5427|109525743|Male|Pituitary|2010|4.8|5.1|5.0
20+|~|~|~|Malignant|~|109525743|Male|Pituitary|2010|~|~|~
20+|4.8|5.1|5.0|Benign/Borderline|5560|110832735|Male|Pituitary|2011|4.9|5.2|5.0
20+|0.0|0.0|0.0|Malignant|21|110832735|Male|Pituitary|2011|0.0|0.0|0.0
20+|5.2|5.5|5.3|Benign/Borderline|6051|112197441|Male|Pituitary|2012|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|19|112197441|Male|Pituitary|2012|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|6110|113445798|Male|Pituitary|2013|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|26|113445798|Male|Pituitary|2013|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|6213|114699102|Male|Pituitary|2014|5.3|5.6|5.4
20+|0.0|0.0|0.0|Malignant|21|114699102|Male|Pituitary|2014|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|31785|579444338|Male|Pituitary|2014-2018|5.4|5.5|5.5
20+|0.0|0.0|0.0|Malignant|79|579444338|Male|Pituitary|2014-2018|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|6427|115921555|Male|Pituitary|2015|5.4|5.7|5.5
20+|0.0|0.0|0.0|Malignant|16|115921555|Male|Pituitary|2015|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6493|117079280|Male|Pituitary|2016|5.4|5.7|5.5
20+|~|~|~|Malignant|~|117079280|Male|Pituitary|2016|~|~|~
20+|5.3|5.5|5.4|Benign/Borderline|6625|118124677|Male|Pituitary|2017|5.5|5.7|5.6
20+|~|~|~|Malignant|~|118124677|Male|Pituitary|2017|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|6220|117924727|Male|Pituitary|2018|5.1|5.4|5.3
20+|~|~|~|Malignant|~|117924727|Male|Pituitary|2018|~|~|~
20+|12.4|12.9|12.7|Benign/Borderline|12346|101938779|Male|Total|2004|11.9|12.3|12.1
20+|10.7|11.1|10.9|Malignant|10649|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.9|14.3|14.1|Benign/Borderline|13953|103190694|Male|Total|2005|13.3|13.7|13.5
20+|10.7|11.1|10.9|Malignant|10812|103190694|Male|Total|2005|10.3|10.7|10.5
20+|14.3|14.7|14.5|Benign/Borderline|14629|104488268|Male|Total|2006|13.8|14.2|14.0
20+|10.5|10.9|10.7|Malignant|10842|104488268|Male|Total|2006|10.2|10.6|10.4
20+|14.7|15.2|14.9|Benign/Borderline|15324|105697783|Male|Total|2007|14.3|14.7|14.5
20+|10.5|10.9|10.7|Malignant|11076|105697783|Male|Total|2007|10.3|10.7|10.5
20+|15.5|16.0|15.8|Benign/Borderline|16502|106947980|Male|Total|2008|15.2|15.7|15.4
20+|10.6|11.0|10.8|Malignant|11384|106947980|Male|Total|2008|10.4|10.8|10.6
20+|16.4|16.9|16.7|Benign/Borderline|17683|108197539|Male|Total|2009|16.1|16.6|16.3
20+|10.5|10.9|10.7|Malignant|11449|108197539|Male|Total|2009|10.4|10.8|10.6
20+|16.4|16.9|16.7|Benign/Borderline|18045|109525743|Male|Total|2010|16.2|16.7|16.5
20+|10.2|10.6|10.4|Malignant|11421|109525743|Male|Total|2010|10.2|10.6|10.4
20+|16.4|16.9|16.7|Benign/Borderline|18415|110832735|Male|Total|2011|16.4|16.9|16.6
20+|10.2|10.6|10.4|Malignant|11664|110832735|Male|Total|2011|10.3|10.7|10.5
20+|17.1|17.6|17.3|Benign/Borderline|19466|112197441|Male|Total|2012|17.1|17.6|17.3
20+|10.1|10.4|10.2|Malignant|11689|112197441|Male|Total|2012|10.2|10.6|10.4
20+|17.2|17.7|17.5|Benign/Borderline|20026|113445798|Male|Total|2013|17.4|17.9|17.7
20+|10.0|10.4|10.2|Malignant|11876|113445798|Male|Total|2013|10.3|10.7|10.5
20+|17.4|17.9|17.6|Benign/Borderline|20543|114699102|Male|Total|2014|17.7|18.2|17.9
20+|10.1|10.5|10.3|Malignant|12195|114699102|Male|Total|2014|10.4|10.8|10.6
20+|17.5|17.7|17.6|Benign/Borderline|105164|579444338|Male|Total|2014-2018|18.0|18.3|18.1
20+|9.9|10.1|10.0|Malignant|60920|579444338|Male|Total|2014-2018|10.4|10.6|10.5
20+|17.7|18.2|17.9|Benign/Borderline|21274|115921555|Male|Total|2015|18.1|18.6|18.4
20+|9.8|10.2|10.0|Malignant|12066|115921555|Male|Total|2015|10.2|10.6|10.4
20+|17.5|18.0|17.7|Benign/Borderline|21364|117079280|Male|Total|2016|18.0|18.5|18.2
20+|9.9|10.3|10.1|Malignant|12481|117079280|Male|Total|2016|10.5|10.8|10.7
20+|17.6|18.1|17.8|Benign/Borderline|21904|118124677|Male|Total|2017|18.3|18.8|18.5
20+|9.8|10.1|10.0|Malignant|12482|118124677|Male|Total|2017|10.4|10.8|10.6
20+|16.5|16.9|16.7|Benign/Borderline|20687|117924727|Male|Total|2018|17.3|17.8|17.5
20+|9.4|9.8|9.6|Malignant|12141|117924727|Male|Total|2018|10.1|10.5|10.3
20+|2.2|2.4|2.3|Benign/Borderline|2330|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2684|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2666|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2752|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2725|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2914|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2930|109525743|Male|Tumors of Cranial and Spinal Nerves|2010|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|109525743|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3033|110832735|Male|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|17|110832735|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|3208|112197441|Male|Tumors of Cranial and Spinal Nerves|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|24|112197441|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3290|113445798|Male|Tumors of Cranial and Spinal Nerves|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113445798|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3557|114699102|Male|Tumors of Cranial and Spinal Nerves|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|114699102|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|17044|579444338|Male|Tumors of Cranial and Spinal Nerves|2014-2018|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|99|579444338|Male|Tumors of Cranial and Spinal Nerves|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3537|115921555|Male|Tumors of Cranial and Spinal Nerves|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|16|115921555|Male|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3437|117079280|Male|Tumors of Cranial and Spinal Nerves|2016|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|22|117079280|Male|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3420|118124677|Male|Tumors of Cranial and Spinal Nerves|2017|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|25|118124677|Male|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|3189|117924727|Male|Tumors of Cranial and Spinal Nerves|2018|2.6|2.8|2.7
20+|~|~|~|Malignant|~|117924727|Male|Tumors of Cranial and Spinal Nerves|2018|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|451|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8969|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|527|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9107|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|560|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9199|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|523|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9403|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|587|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9671|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.9|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|591|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9740|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.2|9.0
20+|0.6|0.6|0.6|Benign/Borderline|649|109525743|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.7|9.0|8.9|Malignant|9769|109525743|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|607|110832735|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.6|9.0|8.8|Malignant|9920|110832735|Male|Tumors of Neuroepthelial Tissue|2011|8.8|9.1|9.0
20+|0.5|0.6|0.6|Benign/Borderline|631|112197441|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|10003|112197441|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|613|113445798|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.6|8.9|8.7|Malignant|10203|113445798|Male|Tumors of Neuroepthelial Tissue|2013|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|681|114699102|Male|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|10351|114699102|Male|Tumors of Neuroepthelial Tissue|2014|8.9|9.2|9.0
20+|0.6|0.6|0.6|Benign/Borderline|3420|579444338|Male|Tumors of Neuroepthelial Tissue|2014-2018|0.6|0.6|0.6
20+|8.4|8.6|8.5|Malignant|52050|579444338|Male|Tumors of Neuroepthelial Tissue|2014-2018|8.9|9.1|9.0
20+|0.6|0.6|0.6|Benign/Borderline|699|115921555|Male|Tumors of Neuroepthelial Tissue|2015|0.6|0.6|0.6
20+|8.3|8.7|8.5|Malignant|10302|115921555|Male|Tumors of Neuroepthelial Tissue|2015|8.7|9.1|8.9
20+|0.6|0.7|0.6|Benign/Borderline|715|117079280|Male|Tumors of Neuroepthelial Tissue|2016|0.6|0.7|0.6
20+|8.5|8.8|8.6|Malignant|10685|117079280|Male|Tumors of Neuroepthelial Tissue|2016|9.0|9.3|9.1
20+|0.5|0.6|0.6|Benign/Borderline|692|118124677|Male|Tumors of Neuroepthelial Tissue|2017|0.5|0.6|0.6
20+|8.4|8.7|8.5|Malignant|10707|118124677|Male|Tumors of Neuroepthelial Tissue|2017|8.9|9.2|9.1
20+|0.5|0.6|0.5|Benign/Borderline|649|117924727|Male|Tumors of Neuroepthelial Tissue|2018|0.5|0.6|0.6
20+|8.0|8.4|8.2|Malignant|10382|117924727|Male|Tumors of Neuroepthelial Tissue|2018|8.6|9.0|8.8
20+|3.5|3.8|3.7|Benign/Borderline|3645|101938779|Male|Tumors of Sellar Region|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|4038|103190694|Male|Tumors of Sellar Region|2005|3.8|4.0|3.9
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|4.0|4.3|4.2|Benign/Borderline|4274|104488268|Male|Tumors of Sellar Region|2006|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4693|105697783|Male|Tumors of Sellar Region|2007|4.3|4.6|4.4
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5088|106947980|Male|Tumors of Sellar Region|2008|4.6|4.9|4.8
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5430|108197539|Male|Tumors of Sellar Region|2009|4.9|5.2|5.0
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|5.0|5.2|5.1|Benign/Borderline|5629|109525743|Male|Tumors of Sellar Region|2010|5.0|5.3|5.1
20+|~|~|~|Malignant|~|109525743|Male|Tumors of Sellar Region|2010|~|~|~
20+|5.0|5.3|5.2|Benign/Borderline|5756|110832735|Male|Tumors of Sellar Region|2011|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|22|110832735|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.4|5.7|5.5|Benign/Borderline|6268|112197441|Male|Tumors of Sellar Region|2012|5.4|5.7|5.6
20+|0.0|0.0|0.0|Malignant|19|112197441|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|6339|113445798|Male|Tumors of Sellar Region|2013|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|26|113445798|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.3|5.6|5.5|Benign/Borderline|6420|114699102|Male|Tumors of Sellar Region|2014|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|24|114699102|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|32914|579444338|Male|Tumors of Sellar Region|2014-2018|5.6|5.7|5.7
20+|0.0|0.0|0.0|Malignant|83|579444338|Male|Tumors of Sellar Region|2014-2018|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6652|115921555|Male|Tumors of Sellar Region|2015|5.6|5.9|5.7
20+|0.0|0.0|0.0|Malignant|16|115921555|Male|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6738|117079280|Male|Tumors of Sellar Region|2016|5.6|5.9|5.8
20+|~|~|~|Malignant|~|117079280|Male|Tumors of Sellar Region|2016|~|~|~
20+|5.5|5.7|5.6|Benign/Borderline|6865|118124677|Male|Tumors of Sellar Region|2017|5.7|6.0|5.8
20+|~|~|~|Malignant|~|118124677|Male|Tumors of Sellar Region|2017|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|6437|117924727|Male|Tumors of Sellar Region|2018|5.3|5.6|5.5
20+|~|~|~|Malignant|~|117924727|Male|Tumors of Sellar Region|2018|~|~|~
20+|5.4|5.7|5.6|Benign/Borderline|5247|101938779|Male|Tumors of the Meninges|2004|5.0|5.3|5.1
20+|0.2|0.2|0.2|Malignant|203|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|6.0|6.3|6.1|Benign/Borderline|5843|103190694|Male|Tumors of the Meninges|2005|5.5|5.8|5.7
20+|0.2|0.2|0.2|Malignant|194|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.2|6.6|6.4|Benign/Borderline|6244|104488268|Male|Tumors of the Meninges|2006|5.8|6.1|6.0
20+|0.2|0.2|0.2|Malignant|186|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.3|6.7|6.5|Benign/Borderline|6460|105697783|Male|Tumors of the Meninges|2007|6.0|6.3|6.1
20+|0.2|0.2|0.2|Malignant|219|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.8|7.2|7.0|Benign/Borderline|7124|106947980|Male|Tumors of the Meninges|2008|6.5|6.8|6.7
20+|0.2|0.2|0.2|Malignant|200|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.3|7.6|7.4|Benign/Borderline|7660|108197539|Male|Tumors of the Meninges|2009|6.9|7.2|7.1
20+|0.2|0.2|0.2|Malignant|201|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|7.1|7.5|7.3|Benign/Borderline|7691|109525743|Male|Tumors of the Meninges|2010|6.9|7.2|7.0
20+|0.1|0.2|0.1|Malignant|159|109525743|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|7.1|7.4|7.3|Benign/Borderline|7855|110832735|Male|Tumors of the Meninges|2011|6.9|7.2|7.1
20+|0.1|0.2|0.2|Malignant|189|110832735|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|7.2|7.5|7.3|Benign/Borderline|8100|112197441|Male|Tumors of the Meninges|2012|7.1|7.4|7.2
20+|0.1|0.2|0.2|Malignant|185|112197441|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.4|7.8|7.6|Benign/Borderline|8560|113445798|Male|Tumors of the Meninges|2013|7.4|7.7|7.5
20+|0.2|0.2|0.2|Malignant|201|113445798|Male|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|7.4|7.7|7.6|Benign/Borderline|8718|114699102|Male|Tumors of the Meninges|2014|7.4|7.8|7.6
20+|0.2|0.2|0.2|Malignant|216|114699102|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|7.7|7.9|7.8|Benign/Borderline|46543|579444338|Male|Tumors of the Meninges|2014-2018|8.0|8.1|8.0
20+|0.2|0.2|0.2|Malignant|1001|579444338|Male|Tumors of the Meninges|2014-2018|0.2|0.2|0.2
20+|7.7|8.0|7.9|Benign/Borderline|9271|115921555|Male|Tumors of the Meninges|2015|7.8|8.2|8.0
20+|0.1|0.2|0.2|Malignant|197|115921555|Male|Tumors of the Meninges|2015|0.1|0.2|0.2
20+|7.7|8.0|7.9|Benign/Borderline|9445|117079280|Male|Tumors of the Meninges|2016|7.9|8.2|8.1
20+|0.1|0.2|0.2|Malignant|203|117079280|Male|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|7.9|8.2|8.1|Benign/Borderline|9917|118124677|Male|Tumors of the Meninges|2017|8.2|8.6|8.4
20+|0.1|0.2|0.2|Malignant|200|118124677|Male|Tumors of the Meninges|2017|0.1|0.2|0.2
20+|7.5|7.8|7.6|Benign/Borderline|9476|117924727|Male|Tumors of the Meninges|2018|7.9|8.2|8.0
20+|0.1|0.2|0.2|Malignant|192|117924727|Male|Tumors of the Meninges|2018|0.1|0.2|0.2
20+|0.6|0.8|0.7|Benign/Borderline|650|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|616|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|829|103190694|Male|Unclassified Tumors|2005|0.7|0.9|0.8
20+|0.6|0.7|0.7|Malignant|613|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|854|104488268|Male|Unclassified Tumors|2006|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|577|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|860|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|574|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|943|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|626|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1051|108197539|Male|Unclassified Tumors|2009|0.9|1.0|1.0
20+|0.6|0.7|0.7|Malignant|651|108197539|Male|Unclassified Tumors|2009|0.6|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1118|109525743|Male|Unclassified Tumors|2010|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|614|109525743|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1139|110832735|Male|Unclassified Tumors|2011|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|625|110832735|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1227|112197441|Male|Unclassified Tumors|2012|1.0|1.2|1.1
20+|0.6|0.7|0.6|Malignant|631|112197441|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1198|113445798|Male|Unclassified Tumors|2013|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|620|113445798|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.9|1.1|1.0|Benign/Borderline|1139|114699102|Male|Unclassified Tumors|2014|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|675|114699102|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|5096|579444338|Male|Unclassified Tumors|2014-2018|0.9|0.9|0.9
20+|0.5|0.6|0.5|Malignant|3124|579444338|Male|Unclassified Tumors|2014-2018|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|1085|115921555|Male|Unclassified Tumors|2015|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|636|115921555|Male|Unclassified Tumors|2015|0.5|0.6|0.5
20+|0.8|0.9|0.9|Benign/Borderline|997|117079280|Male|Unclassified Tumors|2016|0.8|0.9|0.9
20+|0.5|0.6|0.6|Malignant|642|117079280|Male|Unclassified Tumors|2016|0.5|0.6|0.5
20+|0.8|0.9|0.8|Benign/Borderline|977|118124677|Male|Unclassified Tumors|2017|0.8|0.9|0.8
20+|0.4|0.5|0.5|Malignant|568|118124677|Male|Unclassified Tumors|2017|0.4|0.5|0.5
20+|0.7|0.8|0.8|Benign/Borderline|911|117924727|Male|Unclassified Tumors|2018|0.7|0.8|0.8
20+|0.5|0.6|0.5|Malignant|634|117924727|Male|Unclassified Tumors|2018|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|102|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|115|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|138|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|123|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|150|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|161|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|38|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|109525743|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109525743|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|190|110832735|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|110832735|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|176|112197441|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|112197441|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|171|113445798|Male|Unique astrocytoma variants|2013|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|39|113445798|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|114699102|Male|Unique astrocytoma variants|2014|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|114699102|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|945|579444338|Male|Unique astrocytoma variants|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|166|579444338|Male|Unique astrocytoma variants|2014-2018|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|177|115921555|Male|Unique astrocytoma variants|2015|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|115921555|Male|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|196|117079280|Male|Unique astrocytoma variants|2016|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|117079280|Male|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|192|118124677|Male|Unique astrocytoma variants|2017|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|118124677|Male|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|205|117924727|Male|Unique astrocytoma variants|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|29|117924727|Male|Unique astrocytoma variants|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|226139918|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|226139918|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|228729994|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|228729994|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|231348826|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|231348826|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|233748831|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|233748831|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|236195152|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|236195152|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|301|1192408241|Male and Female|All other|2014-2018|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|585|1192408241|Male and Female|All other|2014-2018|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|238554919|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|238554919|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|75|240834729|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|240834729|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|242922830|Male and Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|242922830|Male and Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|83|242530509|Male and Female|All other|2018|0.0|0.0|0.0
20+|0.1|0.2|0.2|Malignant|378|242530509|Male and Female|All other|2018|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1237|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1215|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1211|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1203|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1213|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1216|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1284|226139918|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1280|228729994|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1340|231348826|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1437|233748831|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.6|0.6|Malignant|1407|236195152|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Anaplastic astrocytoma|2014-2018|~|~|~
20+|0.6|0.6|0.6|Malignant|7155|1192408241|Male and Female|Anaplastic astrocytoma|2014-2018|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1480|238554919|Male and Female|Anaplastic astrocytoma|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|1471|240834729|Male and Female|Anaplastic astrocytoma|2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.6|0.6|0.6|Malignant|1450|242922830|Male and Female|Anaplastic astrocytoma|2017|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Anaplastic astrocytoma|2018|~|~|~
20+|0.5|0.6|0.6|Malignant|1388|242530509|Male and Female|Anaplastic astrocytoma|2018|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|395|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|377|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|354|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|345|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|361|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|336|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|330|226139918|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|337|228729994|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|357|231348826|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|375|233748831|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|358|236195152|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Anaplastic oligodendroglioma|2014-2018|~|~|~
20+|0.1|0.2|0.2|Malignant|1817|1192408241|Male and Female|Anaplastic oligodendroglioma|2014-2018|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|354|238554919|Male and Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.2|Malignant|369|240834729|Male and Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|421|242922830|Male and Female|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.2|0.1|Malignant|326|242530509|Male and Female|Anaplastic oligodendroglioma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1209|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1198|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1189|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1163|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1124|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1056|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.5|0.5|Malignant|1099|226139918|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|1047|228729994|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|1052|231348826|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|1016|233748831|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|1092|236195152|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Astrocytoma, NOS|2014-2018|~|~|~
20+|0.5|0.5|0.5|Malignant|5969|1192408241|Male and Female|Astrocytoma, NOS|2014-2018|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.5|0.5|Malignant|1200|238554919|Male and Female|Astrocytoma, NOS|2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|1258|240834729|Male and Female|Astrocytoma, NOS|2016|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.5|0.5|Malignant|1200|242922830|Male and Female|Astrocytoma, NOS|2017|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Astrocytoma, NOS|2018|~|~|~
20+|0.5|0.5|0.5|Malignant|1249|242530509|Male and Female|Astrocytoma, NOS|2018|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|64|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|76|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|90|218481776|Male and Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|78|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|85|226139918|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226139918|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|228729994|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|228729994|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|231348826|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231348826|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|79|233748831|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|233748831|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|88|236195152|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236195152|Male and Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|413|1192408241|Male and Female|Choroid plexus|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|1192408241|Male and Female|Choroid plexus|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|83|238554919|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|238554919|Male and Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|240834729|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|240834729|Male and Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|92|242922830|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|242922830|Male and Female|Choroid plexus|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|80|242530509|Male and Female|Choroid plexus|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|242530509|Male and Female|Choroid plexus|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|392|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|417|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|392|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|420|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|423|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|431|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|441|226139918|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226139918|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|418|228729994|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228729994|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|443|231348826|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231348826|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|473|233748831|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233748831|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|430|236195152|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236195152|Male and Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2281|1192408241|Male and Female|Craniopharyngioma|2014-2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1192408241|Male and Female|Craniopharyngioma|2014-2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|463|238554919|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238554919|Male and Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|467|240834729|Male and Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240834729|Male and Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|484|242922830|Male and Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242922830|Male and Female|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|448|242530509|Male and Female|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242530509|Male and Female|Craniopharyngioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|258|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|350|226139918|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|251|228729994|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|207|231348826|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|174|233748831|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|132|236195152|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Diffuse astrocytoma|2014-2018|~|~|~
20+|0.0|0.0|0.0|Malignant|296|1192408241|Male and Female|Diffuse astrocytoma|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|84|238554919|Male and Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|35|240834729|Male and Female|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Diffuse astrocytoma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|24|242922830|Male and Female|Diffuse astrocytoma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Diffuse astrocytoma|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|21|242530509|Male and Female|Diffuse astrocytoma|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|190|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|216|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|213|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|237|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|198|226139918|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|228729994|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|174|231348826|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|186|233748831|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|180|236195152|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|822|1192408241|Male and Female|Embryonal/primitive/medulloblastoma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|168|238554919|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|182|240834729|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|161|242922830|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|141|242530509|Male and Female|Embryonal/primitive/medulloblastoma|2018|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|270|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|309|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|250|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|260|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|277|226139918|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226139918|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|271|228729994|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|228729994|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|293|231348826|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231348826|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|276|233748831|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|233748831|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|299|236195152|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236195152|Male and Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1398|1192408241|Male and Female|Ependymoma variants|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|1192408241|Male and Female|Ependymoma variants|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|295|238554919|Male and Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|238554919|Male and Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|295|240834729|Male and Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|240834729|Male and Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|276|242922830|Male and Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|242922830|Male and Female|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|243|242530509|Male and Female|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|242530509|Male and Female|Ependymoma variants|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|596|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|604|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|587|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|587|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|633|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|686|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226139918|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|629|226139918|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|228729994|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|597|228729994|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|632|231348826|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|579|233748831|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236195152|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|566|236195152|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|122|1192408241|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|2836|1192408241|Male and Female|Ependymoma/anaplastic ependymoma|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|27|238554919|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|583|238554919|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|20|240834729|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|600|240834729|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|23|242922830|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|585|242922830|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|23|242530509|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|516|242530509|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|55|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|79|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|226139918|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226139918|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|228729994|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|228729994|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|231348826|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|231348826|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|233748831|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|233748831|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|236195152|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|236195152|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|267|1192408241|Male and Female|Germ Cell Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|330|1192408241|Male and Female|Germ Cell Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|238554919|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|238554919|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|240834729|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|76|240834729|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|242922830|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|242922830|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|37|242530509|Male and Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|63|242530509|Male and Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9560|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.5|Malignant|9706|213511339|Male and Female|Glioblastoma|2005|4.5|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9800|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10194|218481776|Male and Female|Glioblastoma|2007|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10416|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.4|4.5|4.4|Malignant|10498|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Glioblastoma|2010|~|~|~
20+|4.4|4.5|4.4|Malignant|10742|226139918|Male and Female|Glioblastoma|2010|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10893|228729994|Male and Female|Glioblastoma|2011|4.7|4.9|4.8
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11392|231348826|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.6|4.5|Malignant|11562|233748831|Male and Female|Glioblastoma|2013|4.9|5.0|4.9
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.5|4.4|Malignant|11601|236195152|Male and Female|Glioblastoma|2014|4.8|5.0|4.9
20+|0.0|0.0|0.0|Benign/Borderline|16|1192408241|Male and Female|Glioblastoma|2014-2018|0.0|0.0|0.0
20+|4.4|4.5|4.5|Malignant|60507|1192408241|Male and Female|Glioblastoma|2014-2018|5.0|5.1|5.1
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Glioblastoma|2015|~|~|~
20+|4.4|4.6|4.5|Malignant|12034|238554919|Male and Female|Glioblastoma|2015|5.0|5.1|5.0
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Glioblastoma|2016|~|~|~
20+|4.4|4.6|4.5|Malignant|12424|240834729|Male and Female|Glioblastoma|2016|5.1|5.3|5.2
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Glioblastoma|2017|~|~|~
20+|4.4|4.6|4.5|Malignant|12535|242922830|Male and Female|Glioblastoma|2017|5.1|5.3|5.2
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Glioblastoma|2018|~|~|~
20+|4.3|4.5|4.4|Malignant|12374|242530509|Male and Female|Glioblastoma|2018|5.0|5.2|5.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|848|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|836|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|845|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|877|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|926|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|970|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|21|226139918|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|819|226139918|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|27|228729994|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|945|228729994|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|231348826|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|926|231348826|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|31|233748831|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|922|233748831|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|40|236195152|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|944|236195152|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|223|1192408241|Male and Female|Glioma malignant, NOS|2014-2018|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|5120|1192408241|Male and Female|Glioma malignant, NOS|2014-2018|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|51|238554919|Male and Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1005|238554919|Male and Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|52|240834729|Male and Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1066|240834729|Male and Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|46|242922830|Male and Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|1125|242922830|Male and Female|Glioma malignant, NOS|2017|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|34|242530509|Male and Female|Glioma malignant, NOS|2018|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1018|242530509|Male and Female|Glioma malignant, NOS|2018|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|457|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|518|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|475|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|528|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|512|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|531|226139918|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226139918|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|525|228729994|Male and Female|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|228729994|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|545|231348826|Male and Female|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|231348826|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|510|233748831|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233748831|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|494|236195152|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236195152|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2603|1192408241|Male and Female|Hemangioblastoma|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|1192408241|Male and Female|Hemangioblastoma|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|537|238554919|Male and Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238554919|Male and Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|545|240834729|Male and Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240834729|Male and Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|550|242922830|Male and Female|Hemangioblastoma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242922830|Male and Female|Hemangioblastoma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|501|242530509|Male and Female|Hemangioblastoma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242530509|Male and Female|Hemangioblastoma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|380|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|487|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|554|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|641|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|800|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|963|223491138|Male and Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1110|226139918|Male and Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226139918|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1224|228729994|Male and Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|228729994|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1236|231348826|Male and Female|Hemangioma|2012|0.5|0.6|0.5
20+|~|~|~|Malignant|~|231348826|Male and Female|Hemangioma|2012|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1237|233748831|Male and Female|Hemangioma|2013|0.5|0.6|0.5
20+|~|~|~|Malignant|~|233748831|Male and Female|Hemangioma|2013|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1166|236195152|Male and Female|Hemangioma|2014|0.5|0.5|0.5
20+|~|~|~|Malignant|~|236195152|Male and Female|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|4949|1192408241|Male and Female|Hemangioma|2014-2018|0.4|0.4|0.4
20+|0.0|0.0|0.0|Malignant|25|1192408241|Male and Female|Hemangioma|2014-2018|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|1032|238554919|Male and Female|Hemangioma|2015|0.4|0.5|0.4
20+|~|~|~|Malignant|~|238554919|Male and Female|Hemangioma|2015|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|961|240834729|Male and Female|Hemangioma|2016|0.4|0.4|0.4
20+|~|~|~|Malignant|~|240834729|Male and Female|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|927|242922830|Male and Female|Hemangioma|2017|0.4|0.4|0.4
20+|~|~|~|Malignant|~|242922830|Male and Female|Hemangioma|2017|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|878|242530509|Male and Female|Hemangioma|2018|0.3|0.4|0.4
20+|~|~|~|Malignant|~|242530509|Male and Female|Hemangioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|50|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|45|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|53|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|54|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|53|226139918|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|43|228729994|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|48|231348826|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|44|233748831|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|52|236195152|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|1192408241|Male and Female|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|198|1192408241|Male and Female|Local Extensions from Regional Tumors|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|42|238554919|Male and Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|42|240834729|Male and Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|36|242922830|Male and Female|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|26|242530509|Male and Female|Local Extensions from Regional Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1341|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1439|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1377|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1476|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|1430|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1506|226139918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1525|228729994|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1464|231348826|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1470|233748831|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1635|236195152|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|~|~|~
20+|0.6|0.6|0.6|Malignant|8176|1192408241|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014-2018|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1581|238554919|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.6|Malignant|1655|240834729|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.6|0.7|0.6|Malignant|1715|242922830|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.6|0.6|0.6|Malignant|1640|242530509|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|0.6|0.7|0.7
20+|8.9|9.1|9.0|Benign/Borderline|19150|211050944|Male and Female|Meningioma|2004|8.9|9.2|9.1
20+|0.2|0.2|0.2|Malignant|445|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.9|10.2|10.1|Benign/Borderline|21788|213511339|Male and Female|Meningioma|2005|10.1|10.3|10.2
20+|0.2|0.2|0.2|Malignant|435|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.4|10.7|10.6|Benign/Borderline|23259|216055494|Male and Female|Meningioma|2006|10.6|10.9|10.8
20+|0.2|0.2|0.2|Malignant|406|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.8|11.1|10.9|Benign/Borderline|24423|218481776|Male and Female|Meningioma|2007|11.0|11.3|11.2
20+|0.2|0.2|0.2|Malignant|444|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.4|11.7|11.5|Benign/Borderline|26334|220975702|Male and Female|Meningioma|2008|11.8|12.1|11.9
20+|0.1|0.2|0.2|Malignant|366|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|12.2|12.4|12.3|Benign/Borderline|28545|223491138|Male and Female|Meningioma|2009|12.6|12.9|12.8
20+|0.1|0.2|0.1|Malignant|352|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.8|12.1|11.9|Benign/Borderline|28183|226139918|Male and Female|Meningioma|2010|12.3|12.6|12.5
20+|0.1|0.2|0.1|Malignant|329|226139918|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.8|12.1|12.0|Benign/Borderline|28808|228729994|Male and Female|Meningioma|2011|12.4|12.7|12.6
20+|0.1|0.2|0.1|Malignant|329|228729994|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|12.0|12.3|12.2|Benign/Borderline|29829|231348826|Male and Female|Meningioma|2012|12.7|13.0|12.9
20+|0.1|0.2|0.1|Malignant|355|231348826|Male and Female|Meningioma|2012|0.1|0.2|0.2
20+|12.2|12.5|12.3|Benign/Borderline|30791|233748831|Male and Female|Meningioma|2013|13.0|13.3|13.2
20+|0.1|0.2|0.2|Malignant|384|233748831|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|12.4|12.6|12.5|Benign/Borderline|31802|236195152|Male and Female|Meningioma|2014|13.3|13.6|13.5
20+|0.1|0.2|0.1|Malignant|382|236195152|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|12.7|12.8|12.8|Benign/Borderline|167301|1192408241|Male and Female|Meningioma|2014-2018|14.0|14.1|14.0
20+|0.1|0.1|0.1|Malignant|1672|1192408241|Male and Female|Meningioma|2014-2018|0.1|0.1|0.1
20+|12.7|13.0|12.8|Benign/Borderline|33331|238554919|Male and Female|Meningioma|2015|13.8|14.1|14.0
20+|0.1|0.2|0.1|Malignant|350|238554919|Male and Female|Meningioma|2015|0.1|0.2|0.1
20+|12.8|13.1|13.0|Benign/Borderline|34166|240834729|Male and Female|Meningioma|2016|14.0|14.3|14.2
20+|0.1|0.1|0.1|Malignant|329|240834729|Male and Female|Meningioma|2016|0.1|0.2|0.1
20+|12.9|13.2|13.1|Benign/Borderline|35160|242922830|Male and Female|Meningioma|2017|14.3|14.6|14.5
20+|0.1|0.1|0.1|Malignant|325|242922830|Male and Female|Meningioma|2017|0.1|0.1|0.1
20+|12.3|12.6|12.5|Benign/Borderline|33865|242530509|Male and Female|Meningioma|2018|13.8|14.1|14.0
20+|0.1|0.1|0.1|Malignant|297|242530509|Male and Female|Meningioma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|493|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|566|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|639|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|587|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|601|220975702|Male and Female|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|680|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|613|226139918|Male and Female|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|636|228729994|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|574|231348826|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|619|233748831|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|468|236195152|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Mixed glioma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|925|1192408241|Male and Female|Mixed glioma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|275|238554919|Male and Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.0|Malignant|108|240834729|Male and Female|Mixed glioma|2016|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|59|242922830|Male and Female|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Mixed glioma|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|21|242530509|Male and Female|Mixed glioma|2018|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|1197|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1312|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1499|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1323|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1423|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1287|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1425|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1218|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1448|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1369|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1537|223491138|Male and Female|Neoplasm, unspecified|2009|0.7|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1423|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1494|226139918|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1248|226139918|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1480|228729994|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1255|228729994|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|1590|231348826|Male and Female|Neoplasm, unspecified|2012|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|1272|231348826|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1484|233748831|Male and Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1275|233748831|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1515|236195152|Male and Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1401|236195152|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|6791|1192408241|Male and Female|Neoplasm, unspecified|2014-2018|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6424|1192408241|Male and Female|Neoplasm, unspecified|2014-2018|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1479|238554919|Male and Female|Neoplasm, unspecified|2015|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1357|238554919|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|1360|240834729|Male and Female|Neoplasm, unspecified|2016|0.5|0.6|0.6
20+|0.4|0.5|0.5|Malignant|1240|240834729|Male and Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.5|0.5|0.5|Benign/Borderline|1296|242922830|Male and Female|Neoplasm, unspecified|2017|0.5|0.6|0.5
20+|0.4|0.5|0.4|Malignant|1233|242922830|Male and Female|Neoplasm, unspecified|2017|0.5|0.5|0.5
20+|0.4|0.5|0.4|Benign/Borderline|1164|242530509|Male and Female|Neoplasm, unspecified|2018|0.5|0.5|0.5
20+|0.4|0.5|0.5|Malignant|1251|242530509|Male and Female|Neoplasm, unspecified|2018|0.5|0.5|0.5
20+|2.2|2.4|2.3|Benign/Borderline|4902|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5528|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5638|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5729|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5824|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6169|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5996|226139918|Male and Female|Nerve sheath, benign and malignant|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|45|226139918|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6351|228729994|Male and Female|Nerve sheath, benign and malignant|2011|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|38|228729994|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|6723|231348826|Male and Female|Nerve sheath, benign and malignant|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|50|231348826|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|6975|233748831|Male and Female|Nerve sheath, benign and malignant|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|233748831|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.9|3.0|2.9|Benign/Borderline|7363|236195152|Male and Female|Nerve sheath, benign and malignant|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|39|236195152|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|35531|1192408241|Male and Female|Nerve sheath, benign and malignant|2014-2018|2.9|3.0|3.0
20+|0.0|0.0|0.0|Malignant|197|1192408241|Male and Female|Nerve sheath, benign and malignant|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7412|238554919|Male and Female|Nerve sheath, benign and malignant|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|39|238554919|Male and Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7240|240834729|Male and Female|Nerve sheath, benign and malignant|2016|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|48|240834729|Male and Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|7091|242922830|Male and Female|Nerve sheath, benign and malignant|2017|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|43|242922830|Male and Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6596|242530509|Male and Female|Nerve sheath, benign and malignant|2018|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|28|242530509|Male and Female|Nerve sheath, benign and malignant|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226139918|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|53|228729994|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|55|231348826|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|48|233748831|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|57|236195152|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|1192408241|Male and Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|230|1192408241|Male and Female|Neuroepithelial|2014-2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|70|238554919|Male and Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|47|240834729|Male and Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|34|242922830|Male and Female|Neuroepithelial|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Neuroepithelial|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|23|242530509|Male and Female|Neuroepithelial|2018|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|315|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|377|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|387|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|390|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|422|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|440|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|482|226139918|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|226139918|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|430|228729994|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|39|228729994|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|419|231348826|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|231348826|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|397|233748831|Male and Female|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|233748831|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|462|236195152|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|236195152|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2367|1192408241|Male and Female|Neuronal/glial, neuronal|2014-2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|167|1192408241|Male and Female|Neuronal/glial, neuronal|2014-2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|496|238554919|Male and Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|238554919|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|480|240834729|Male and Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|48|240834729|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|501|242922830|Male and Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|242922830|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|440|242530509|Male and Female|Neuronal/glial, neuronal|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|242530509|Male and Female|Neuronal/glial, neuronal|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|833|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|802|213511339|Male and Female|Oligodendroglioma|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|850|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|813|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|776|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|840|223491138|Male and Female|Oligodendroglioma|2009|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|800|226139918|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|764|228729994|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|671|231348826|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|717|233748831|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|720|236195152|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Oligodendroglioma|2014-2018|~|~|~
20+|0.3|0.3|0.3|Malignant|3527|1192408241|Male and Female|Oligodendroglioma|2014-2018|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Oligodendroglioma|2015|~|~|~
20+|0.3|0.3|0.3|Malignant|714|238554919|Male and Female|Oligodendroglioma|2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|739|240834729|Male and Female|Oligodendroglioma|2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Oligodendroglioma|2017|~|~|~
20+|0.3|0.3|0.3|Malignant|719|242922830|Male and Female|Oligodendroglioma|2017|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Oligodendroglioma|2018|~|~|~
20+|0.3|0.3|0.3|Malignant|657|242530509|Male and Female|Oligodendroglioma|2018|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|151|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|63|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|165|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|208|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|98|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|174|226139918|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|226139918|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|161|228729994|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|228729994|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|201|231348826|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|231348826|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|179|233748831|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|84|233748831|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|182|236195152|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|82|236195152|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|886|1192408241|Male and Female|Other mesenchymal|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|454|1192408241|Male and Female|Other mesenchymal|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|238554919|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|85|238554919|Male and Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|160|240834729|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|79|240834729|Male and Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|185|242922830|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|110|242922830|Male and Female|Other mesenchymal|2017|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|163|242530509|Male and Female|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|102|242530509|Male and Female|Other mesenchymal|2018|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|279|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|305|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|306|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|308|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|290|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|273|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226139918|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|330|226139918|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228729994|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|336|228729994|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231348826|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|270|231348826|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233748831|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|303|233748831|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236195152|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|299|236195152|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192408241|Male and Female|Pilocytic astrocytoma|2014-2018|~|~|~
20+|0.1|0.1|0.1|Malignant|1413|1192408241|Male and Female|Pilocytic astrocytoma|2014-2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238554919|Male and Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|296|238554919|Male and Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240834729|Male and Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|298|240834729|Male and Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242922830|Male and Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|266|242922830|Male and Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242530509|Male and Female|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|262|242530509|Male and Female|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|50|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|46|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|226139918|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226139918|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|228729994|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|228729994|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|231348826|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231348826|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|233748831|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|233748831|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|236195152|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|236195152|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|288|1192408241|Male and Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|248|1192408241|Male and Female|Pineal parenchymal|2014-2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|238554919|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238554919|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|240834729|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|63|240834729|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|52|242922830|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|242922830|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|242530509|Male and Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|39|242530509|Male and Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|7632|211050944|Male and Female|Pituitary|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|4.0|4.1|4.1|Benign/Borderline|8668|213511339|Male and Female|Pituitary|2005|4.0|4.1|4.1
20+|0.0|0.0|0.0|Malignant|37|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.3|4.4|4.4|Benign/Borderline|9437|216055494|Male and Female|Pituitary|2006|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|10058|218481776|Male and Female|Pituitary|2007|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|10904|220975702|Male and Female|Pituitary|2008|4.8|5.0|4.9
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|5.2|5.4|5.3|Benign/Borderline|11845|223491138|Male and Female|Pituitary|2009|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|12060|226139918|Male and Female|Pituitary|2010|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|31|226139918|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12383|228729994|Male and Female|Pituitary|2011|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|33|228729994|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|13357|231348826|Male and Female|Pituitary|2012|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|34|231348826|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.6|5.7|5.7|Benign/Borderline|13359|233748831|Male and Female|Pituitary|2013|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|41|233748831|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13594|236195152|Male and Female|Pituitary|2014|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|34|236195152|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|5.7|5.8|5.8|Benign/Borderline|69814|1192408241|Male and Female|Pituitary|2014-2018|5.8|5.9|5.9
20+|0.0|0.0|0.0|Malignant|124|1192408241|Male and Female|Pituitary|2014-2018|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14139|238554919|Male and Female|Pituitary|2015|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|30|238554919|Male and Female|Pituitary|2015|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|14235|240834729|Male and Female|Pituitary|2016|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|22|240834729|Male and Female|Pituitary|2016|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14605|242922830|Male and Female|Pituitary|2017|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|19|242922830|Male and Female|Pituitary|2017|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|13639|242530509|Male and Female|Pituitary|2018|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|19|242530509|Male and Female|Pituitary|2018|0.0|0.0|0.0
20+|16.4|16.7|16.5|Benign/Borderline|35140|211050944|Male and Female|Total|2004|16.5|16.8|16.7
20+|9.0|9.3|9.1|Malignant|19400|211050944|Male and Female|Total|2004|9.1|9.3|9.2
20+|18.4|18.8|18.6|Benign/Borderline|40111|213511339|Male and Female|Total|2005|18.6|19.0|18.8
20+|9.0|9.3|9.1|Malignant|19736|213511339|Male and Female|Total|2005|9.1|9.4|9.2
20+|19.2|19.6|19.4|Benign/Borderline|42479|216055494|Male and Female|Total|2006|19.5|19.8|19.7
20+|8.9|9.2|9.0|Malignant|19831|216055494|Male and Female|Total|2006|9.1|9.3|9.2
20+|19.8|20.1|20.0|Benign/Borderline|44426|218481776|Male and Female|Total|2007|20.1|20.5|20.3
20+|8.9|9.2|9.0|Malignant|20163|218481776|Male and Female|Total|2007|9.1|9.4|9.2
20+|20.9|21.2|21.1|Benign/Borderline|47631|220975702|Male and Female|Total|2008|21.4|21.7|21.6
20+|8.9|9.2|9.1|Malignant|20617|220975702|Male and Female|Total|2008|9.2|9.5|9.3
20+|22.2|22.6|22.4|Benign/Borderline|51399|223491138|Male and Female|Total|2009|22.8|23.2|23.0
20+|8.9|9.1|9.0|Malignant|20834|223491138|Male and Female|Total|2009|9.2|9.4|9.3
20+|21.7|22.1|21.9|Benign/Borderline|51254|226139918|Male and Female|Total|2010|22.5|22.9|22.7
20+|8.7|8.9|8.8|Malignant|20747|226139918|Male and Female|Total|2010|9.0|9.3|9.2
20+|22.0|22.4|22.2|Benign/Borderline|52595|228729994|Male and Female|Total|2011|22.8|23.2|23.0
20+|8.6|8.8|8.7|Malignant|20873|228729994|Male and Female|Total|2011|9.0|9.3|9.1
20+|22.7|23.1|22.9|Benign/Borderline|55171|231348826|Male and Female|Total|2012|23.6|24.0|23.8
20+|8.5|8.8|8.7|Malignant|21171|231348826|Male and Female|Total|2012|9.0|9.3|9.2
20+|22.8|23.1|22.9|Benign/Borderline|56211|233748831|Male and Female|Total|2013|23.8|24.2|24.0
20+|8.5|8.8|8.6|Malignant|21531|233748831|Male and Female|Total|2013|9.1|9.3|9.2
20+|23.1|23.5|23.3|Benign/Borderline|57895|236195152|Male and Female|Total|2014|24.3|24.7|24.5
20+|8.5|8.7|8.6|Malignant|21708|236195152|Male and Female|Total|2014|9.1|9.3|9.2
20+|23.2|23.4|23.3|Benign/Borderline|296837|1192408241|Male and Female|Total|2014-2018|24.8|25.0|24.9
20+|8.3|8.4|8.4|Malignant|109114|1192408241|Male and Female|Total|2014-2018|9.1|9.2|9.2
20+|23.5|23.9|23.7|Benign/Borderline|59981|238554919|Male and Female|Total|2015|24.9|25.3|25.1
20+|8.4|8.6|8.5|Malignant|21980|238554919|Male and Female|Total|2015|9.1|9.3|9.2
20+|23.4|23.8|23.6|Benign/Borderline|60509|240834729|Male and Female|Total|2016|24.9|25.3|25.1
20+|8.4|8.6|8.5|Malignant|22300|240834729|Male and Female|Total|2016|9.1|9.4|9.3
20+|23.4|23.8|23.6|Benign/Borderline|61656|242922830|Male and Female|Total|2017|25.2|25.6|25.4
20+|8.2|8.5|8.4|Malignant|22314|242922830|Male and Female|Total|2017|9.1|9.3|9.2
20+|22.1|22.4|22.2|Benign/Borderline|58501|242530509|Male and Female|Total|2018|23.9|24.3|24.1
20+|7.9|8.1|8.0|Malignant|21582|242530509|Male and Female|Total|2018|8.8|9.0|8.9
20+|2.2|2.4|2.3|Benign/Borderline|4902|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5531|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5640|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5731|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5828|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6176|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6000|226139918|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|45|226139918|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6356|228729994|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|38|228729994|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|6725|231348826|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|50|231348826|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|6980|233748831|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|233748831|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.9|3.0|2.9|Benign/Borderline|7372|236195152|Male and Female|Tumors of Cranial and Spinal Nerves|2014|3.1|3.2|3.1
20+|0.0|0.0|0.0|Malignant|39|236195152|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|35565|1192408241|Male and Female|Tumors of Cranial and Spinal Nerves|2014-2018|3.0|3.0|3.0
20+|0.0|0.0|0.0|Malignant|197|1192408241|Male and Female|Tumors of Cranial and Spinal Nerves|2014-2018|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7422|238554919|Male and Female|Tumors of Cranial and Spinal Nerves|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|39|238554919|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7248|240834729|Male and Female|Tumors of Cranial and Spinal Nerves|2016|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|48|240834729|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|7096|242922830|Male and Female|Tumors of Cranial and Spinal Nerves|2017|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|43|242922830|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6599|242530509|Male and Female|Tumors of Cranial and Spinal Nerves|2018|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|28|242530509|Male and Female|Tumors of Cranial and Spinal Nerves|2018|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|832|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.7|7.5|Malignant|16037|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|973|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16259|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1043|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16435|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1009|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16807|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1079|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17096|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.9|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1105|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17372|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.7|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1195|226139918|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|7.3|7.5|7.4|Malignant|17377|226139918|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1172|228729994|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17481|228729994|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.8|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1176|231348826|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17808|231348826|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1139|233748831|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|18119|233748831|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.6|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1278|236195152|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|17984|236195152|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.5|7.7|7.6
20+|0.5|0.6|0.5|Benign/Borderline|6340|1192408241|Male and Female|Tumors of Neuroepthelial Tissue|2014-2018|0.5|0.5|0.5
20+|7.0|7.1|7.0|Malignant|91403|1192408241|Male and Female|Tumors of Neuroepthelial Tissue|2014-2018|7.6|7.7|7.7
20+|0.5|0.6|0.6|Benign/Borderline|1311|238554919|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.5
20+|7.1|7.3|7.2|Malignant|18414|238554919|Male and Female|Tumors of Neuroepthelial Tissue|2015|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1301|240834729|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.5|0.6|0.5
20+|7.0|7.3|7.2|Malignant|18782|240834729|Male and Female|Tumors of Neuroepthelial Tissue|2016|7.7|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1290|242922830|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.5|0.6|0.5
20+|6.9|7.1|7.0|Malignant|18745|242922830|Male and Female|Tumors of Neuroepthelial Tissue|2017|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1193|242530509|Male and Female|Tumors of Neuroepthelial Tissue|2018|0.5|0.5|0.5
20+|6.6|6.8|6.7|Malignant|18122|242530509|Male and Female|Tumors of Neuroepthelial Tissue|2018|7.4|7.6|7.5
20+|3.7|3.9|3.8|Benign/Borderline|8024|211050944|Male and Female|Tumors of Sellar Region|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.2|4.3|4.2|Benign/Borderline|9085|213511339|Male and Female|Tumors of Sellar Region|2005|4.2|4.3|4.3
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9829|216055494|Male and Female|Tumors of Sellar Region|2006|4.5|4.6|4.5
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|10478|218481776|Male and Female|Tumors of Sellar Region|2007|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|11327|220975702|Male and Female|Tumors of Sellar Region|2008|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Tumors of Sellar Region|2008|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12276|223491138|Male and Female|Tumors of Sellar Region|2009|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12501|226139918|Male and Female|Tumors of Sellar Region|2010|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|31|226139918|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|12801|228729994|Male and Female|Tumors of Sellar Region|2011|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|35|228729994|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|13800|231348826|Male and Female|Tumors of Sellar Region|2012|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|34|231348826|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|13832|233748831|Male and Female|Tumors of Sellar Region|2013|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|42|233748831|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14024|236195152|Male and Female|Tumors of Sellar Region|2014|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|38|236195152|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.9|6.0|6.0|Benign/Borderline|72095|1192408241|Male and Female|Tumors of Sellar Region|2014-2018|6.0|6.1|6.0
20+|0.0|0.0|0.0|Malignant|131|1192408241|Male and Female|Tumors of Sellar Region|2014-2018|0.0|0.0|0.0
20+|6.0|6.2|6.1|Benign/Borderline|14602|238554919|Male and Female|Tumors of Sellar Region|2015|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|31|238554919|Male and Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|14702|240834729|Male and Female|Tumors of Sellar Region|2016|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|23|240834729|Male and Female|Tumors of Sellar Region|2016|0.0|0.0|0.0
20+|6.0|6.2|6.1|Benign/Borderline|15089|242922830|Male and Female|Tumors of Sellar Region|2017|6.1|6.3|6.2
20+|0.0|0.0|0.0|Malignant|20|242922830|Male and Female|Tumors of Sellar Region|2017|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|14087|242530509|Male and Female|Tumors of Sellar Region|2018|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|19|242530509|Male and Female|Tumors of Sellar Region|2018|0.0|0.0|0.0
20+|9.2|9.4|9.3|Benign/Borderline|19758|211050944|Male and Female|Tumors of the Meninges|2004|9.2|9.5|9.4
20+|0.2|0.3|0.2|Malignant|503|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.3|10.5|10.4|Benign/Borderline|22461|213511339|Male and Female|Tumors of the Meninges|2005|10.4|10.7|10.5
20+|0.2|0.3|0.2|Malignant|501|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.7|11.0|10.9|Benign/Borderline|23913|216055494|Male and Female|Tumors of the Meninges|2006|10.9|11.2|11.1
20+|0.2|0.2|0.2|Malignant|469|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|11.1|11.4|11.2|Benign/Borderline|25063|218481776|Male and Female|Tumors of the Meninges|2007|11.3|11.6|11.5
20+|0.2|0.3|0.2|Malignant|529|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.7|12.0|11.9|Benign/Borderline|27070|220975702|Male and Female|Tumors of the Meninges|2008|12.1|12.4|12.3
20+|0.2|0.2|0.2|Malignant|470|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.5|12.8|12.6|Benign/Borderline|29257|223491138|Male and Female|Tumors of the Meninges|2009|12.9|13.2|13.1
20+|0.2|0.2|0.2|Malignant|431|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|12.1|12.4|12.2|Benign/Borderline|28888|226139918|Male and Female|Tumors of the Meninges|2010|12.6|12.9|12.8
20+|0.2|0.2|0.2|Malignant|402|226139918|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|12.1|12.4|12.3|Benign/Borderline|29494|228729994|Male and Female|Tumors of the Meninges|2011|12.7|13.0|12.9
20+|0.2|0.2|0.2|Malignant|406|228729994|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|12.3|12.6|12.5|Benign/Borderline|30575|231348826|Male and Female|Tumors of the Meninges|2012|13.1|13.4|13.2
20+|0.2|0.2|0.2|Malignant|426|231348826|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|12.5|12.8|12.6|Benign/Borderline|31480|233748831|Male and Female|Tumors of the Meninges|2013|13.3|13.6|13.5
20+|0.2|0.2|0.2|Malignant|472|233748831|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|12.6|12.9|12.8|Benign/Borderline|32478|236195152|Male and Female|Tumors of the Meninges|2014|13.6|13.9|13.8
20+|0.2|0.2|0.2|Malignant|471|236195152|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|13.0|13.1|13.1|Benign/Borderline|170790|1192408241|Male and Female|Tumors of the Meninges|2014-2018|14.3|14.4|14.3
20+|0.2|0.2|0.2|Malignant|2159|1192408241|Male and Female|Tumors of the Meninges|2014-2018|0.2|0.2|0.2
20+|13.0|13.3|13.1|Benign/Borderline|34068|238554919|Male and Female|Tumors of the Meninges|2015|14.1|14.4|14.3
20+|0.2|0.2|0.2|Malignant|440|238554919|Male and Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|13.1|13.4|13.3|Benign/Borderline|34871|240834729|Male and Female|Tumors of the Meninges|2016|14.3|14.6|14.5
20+|0.1|0.2|0.2|Malignant|416|240834729|Male and Female|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|13.2|13.5|13.4|Benign/Borderline|35895|242922830|Male and Female|Tumors of the Meninges|2017|14.6|14.9|14.8
20+|0.2|0.2|0.2|Malignant|441|242922830|Male and Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|12.6|12.9|12.7|Benign/Borderline|34529|242530509|Male and Female|Tumors of the Meninges|2018|14.1|14.4|14.2
20+|0.1|0.2|0.2|Malignant|406|242530509|Male and Female|Tumors of the Meninges|2018|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|1583|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|1325|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1991|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1336|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1987|216055494|Male and Female|Unclassified Tumors|2006|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|1303|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2072|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1229|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2258|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|1393|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2503|223491138|Male and Female|Unclassified Tumors|2009|1.1|1.2|1.1
20+|0.6|0.7|0.6|Malignant|1441|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2609|226139918|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1269|226139918|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2709|228729994|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1276|228729994|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2827|231348826|Male and Female|Unclassified Tumors|2012|1.2|1.3|1.2
20+|0.5|0.6|0.5|Malignant|1289|231348826|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2728|233748831|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.2
20+|0.5|0.5|0.5|Malignant|1289|233748831|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2684|236195152|Male and Female|Unclassified Tumors|2014|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|1420|236195152|Male and Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|11763|1192408241|Male and Female|Unclassified Tumors|2014-2018|1.0|1.0|1.0
20+|0.5|0.5|0.5|Malignant|6520|1192408241|Male and Female|Unclassified Tumors|2014-2018|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|2515|238554919|Male and Female|Unclassified Tumors|2015|1.0|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1373|238554919|Male and Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2324|240834729|Male and Female|Unclassified Tumors|2016|0.9|1.0|1.0
20+|0.4|0.5|0.5|Malignant|1258|240834729|Male and Female|Unclassified Tumors|2016|0.5|0.6|0.5
20+|0.8|0.9|0.9|Benign/Borderline|2229|242922830|Male and Female|Unclassified Tumors|2017|0.9|1.0|0.9
20+|0.4|0.5|0.5|Malignant|1249|242922830|Male and Female|Unclassified Tumors|2017|0.5|0.5|0.5
20+|0.8|0.8|0.8|Benign/Borderline|2049|242530509|Male and Female|Unclassified Tumors|2018|0.8|0.9|0.8
20+|0.4|0.5|0.5|Malignant|1278|242530509|Male and Female|Unclassified Tumors|2018|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|156|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|158|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|188|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|186|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|210|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|237|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|254|226139918|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226139918|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|270|228729994|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|60|228729994|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|278|231348826|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|231348826|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|267|233748831|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|233748831|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|280|236195152|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|236195152|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1455|1192408241|Male and Female|Unique astrocytoma variants|2014-2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|322|1192408241|Male and Female|Unique astrocytoma variants|2014-2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|282|238554919|Male and Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|50|238554919|Male and Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|306|240834729|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|240834729|Male and Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|288|242922830|Male and Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|70|242922830|Male and Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|305|242530509|Male and Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|242530509|Male and Female|Unique astrocytoma variants|2018|0.0|0.0|0.0
